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1.
Multidisciplinary Rehabilitation Program in Patients with
Advanced Heart Failure after Cardiac Resynchronization
Therapy
KY NG,1 K FAN,1 G YIP,1 JYY NG,2 B YUNK,2 KYP CHAN,1 KY CHENG,1
KW LAI,1 KW SIT,1 D CHAN2
1
Cardiac Rehabilitation Center, Cardiac Medical Unit; 2Physiotherapy
Department, Grantham Hospital, Hong Kong
Introduction: Cardiac resynchronization therapy (CRT) has been proven to
improve functional class and systolic function in heart failure patients
(NYHA class III- ambulatory IV) and additional cardiac rehabilitation
program with exercise training in this high risk group remains to be
determined.
Objective: The objective of this program was to assess further improvement
of exercise capacity of patients with advanced heart failure after CRT through
multidisciplinary cardiac rehabilitation program.
Methods: Twelve patients (5 women and 7 men; mean age 48, ranged 1870) who received CRT (mean duration of 2.2 months) further completed an
8-week multidisciplinary cardiac rehabilitation program with aerobic exercise
training (including 3 sessions/week with a total of 24 sessions & 40 minutes/
session on treadmill walking & cycling) plus specific counseling services
on heart failure disease with emphasis on patients' self-management, in the
Cardiac Rehabilitation Center of Grantham Hospital. Cardiopulmonary
exercise test (CPET) and six-minute hall walk (6-MWT) were assessed and
compared at baseline (before implantation of CRT), after CRT and after
rehabilitation respectively.
Results: There were statistically significantly further improvement on the
duration (seconds) of the CPET (614±166 to 743.46±147, p<0.001), peak
VO2 (ml/kg/min.) (17.44±4.76 to 20.11+5.36, p<0.001), MET level (4.97±

1.37 to 5.73±1.53, p<0.001), oxygen pulse (9.46±3.76 to 10.58±3.36,
p<0.05), VE/VCO2 (39.42±8.40 to 36.58±7.82, p<0.05) as well as 6-MWT
(meters) (433±58.95 to 494.33±74.77, p<0.001) after the 8-week
rehabilitation program. After physicians' assessment, 4 subjects out of 6
(who were originally on heart transplantation work up) were deleted from
the heart transplantation waiting list due to the improvement of functional
class to NYHA class II.
Conclusions: Well prescribed exercise training program specifically designed
for heart failure patients who received evidence-based heart failure therapy
is beneficial and safe. Additional multidisciplinary intervention further
improved patients' well being.

2.
The Role of Personal Resources in Patients with Coronary Heart
Disease in Response to Cardiac Rehabilitation Program
KWN WONG,1 ST KWOK2
Faculty of Science and Technology, The Technological and Higher
Education Institute of Hong Kong; 2School of Nursing, The Hong Kong
Polytechnic University, Hong Kong

1

Purpose of the Study: This study investigated the impact of personal
resources (including optimism, self-esteem, perceived control, social support,
and gratitude) on outcome measures in Chinese coronary heart disease (CHD)
patients in response to a cardiac rehabilitation program. The posttraumatic
growth among Chinese CHD patients and how far personal resources
predicted posttraumatic growth among these patients were also examined.
Methods: 67 Chinese patients with CHD went through an 8-week cardiac
rehabilitation program that consisted of structured exercise sessions, nursing
care, and health education and promotion. Physiological impairment
parameters were assessed pre- and post-program. Blood profiles were
obtained during the first consultation and subsequent follow-up at the cardiac
centre. Personal resources data and general health status were collected in
the first consultation while the posttraumatic growth data and the post
program general health status were collected at the last session of the
program.
Results: Results indicated that CHD patients high in personal resources
achieved better outcomes than those low in personal resources, as indicated
by higher physical and mental summary measures in SF-36, lower cholesterol
levels and better performance on the 6-minute walk test. Moreover, personal
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resources were demonstrated to be a significant predictor of the level of
posttraumatic growth although the rehabilitation program exerted a weak
mediating effect on the link between personal resources and posttraumatic
growth.
Conclusion: Human beings are able to experience growth after a lifethreatening disease, and this can be predicted by individual difference in
personal resources. In addition to teaching the client to manage their physical
health in rehabilitation program, it may be beneficial to incorporate trainings
or interventions in the rehabilitation program to increase personal resources
of individuals.
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Six Minute Walk Distance in Patients after Phase I Cardiac
Rehabilitation Prgroams
SF HSIAO,1 PC LU,1 YJ LIN,1 CS LIN,1 SY CHEN,1 SS WANG,2 RB HSU,2
C LAN,1 JS LAI1
1
Department of Physical Medicine and Rehabilitation; 2Department of
Surgery, National Taiwan University Hospital, Taipei, Taiwan
Purpose: Phase I cardiac rehabilitation program (CRP) delivers preventive
and rehabilitative services to hospitalized patients following acute coronary
syndrome or cardiac surgery. The literatures on the exercise capacity of
patients after phase I CPR was scarce. Six-minute walk test (6MWT) is easy
and simple to administer and enables to indicate the exercise capacity of
patients with cardiac or pulmonary diseases. The purposes of this study
were to investigate 6MWT of patients after phase I CPR before discharge
and to explore its correlated factors.
Materials and Methods: We retrospectively reviewed the medical records
of patients who were referred to phase I CRP in our medical center from
January 2011 to December 2011. Phase I CRP and 6MWT were performed
by physical therapist during hospitalization before discharge.
Results: Our study subjects were 203 male and 63 female patients with
mean age of 57.2±14.0 years; weight: 64.6±12.1 kg; height: 163.7±8.0 cm,
left ventricular ejection fraction: 61.21±12.95%. The diagnosis of phase I
CRP referral included percutaneous coronary intervention (n=28, 10.5%),
coronary artery bypass surgery (n=110, 41.4%), and other cardiac surgery
(n=128, 48.1%). Their risk factors of cardiovascular diseases included
diabetes (32.0%), dyslipidemia (26.3%), and hypertension (57.5%). Distance
walked in 6MWT in all subjects was 312.3±86.7 m. Heart rate increased

11.9±10.6 beat/min. Systolic blood pressure (SBP) elevated 10.6±
14.7 mmHg. Abnormal SBP drop more than 10 mmHg was rare (n=9,
3.3%). Obvious heart rate drop of more than 10 beat/min was only observed
in 2 subjects. Body height corrected walking distance was less in elder group
(278.2±78.8 m versus 329.5±85.6 m, p<0.0001). Findings of 6MWT distance
were not significantly correlated with diagnosis and risk factors of
cardiovascular diseases.
Conclusions: At the end of phase I CRP, 6MWT can be safely performed
among ambulatory patients. The elder cardiac patients had significantly
shorter 6MWT distance.

4.
Is There a Significant Improvement in Heart Rate Recovery Over
Cardiac Rehabilitation Programs?
A AHMAD
Department of Physiotherapy & Rehabilitation, National Heart Institute,
Kuala Lumpur, Malaysia
Background: The fall in heart rate (heart rate recovery) immediately after
exercise is a marker of vagal tone that findings have shown to be a powerful
predictor of all caused mortality. Heart rate recovery should be evaluated
before and after completion of cardiac rehabilitation program. The purpose
of this study aimed to evaluate the effect of exercise based cardiac
rehabilitation on heart rate recovery.
Method: Each individual entering the Phase II cardiac rehabilitation program
undertakes a pre assessment. In all of our pre and post assessment, the step
test is used as our measure of cardiovascular fitness, prognostic marker
mortality and the patient's perceived workload. For this abstract the step
test result will be presented as a measure of each patient's progress throughout
phase II. The step test requires stepping up and down onto 12-inch step for
one minute. The heart rate is then taken for 60 seconds to show signs of
recovery and the patients Borg rating perceived exertion (RPE) is assessed.
The analyses of the result are presented by comparing the pre and post
assessment step test heart rate and results.
Results: 48 patients who completed Phase II of the cardiac rehabilitation
program between January to April 2012 were analyzed. The sample consisted
of 48 patients; (24 cardiology cases vs. 24 cardiothoracic cases) age range
29 years-77 years (mean = 56 years). Thirty-nine (92%) of the patients
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showed an improvement as measured by heart rate recovery and RPE. Of
the remaining patients 9 (21.4%) showed no improvement within both group
after 4 weeks cardiac rehabilitation program demonstrates significant change
in heart rate recovery. Among this two group, cardiology patients showed a
significant improvement 14 (58.3%) before enrolling for cardiac
rehabilitation program increased to 23 (95.8%) after completed the program.
Conclusion: Regular structured exercise in cardiac rehabilitation program
increases functional capacity. A simple functional exercise assessment is a
valuable way to audit Phase II cardiac rehabilitation. It is also a good way
of providing objective feedback to the patient.
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Health Education of Intensive Cardiac Rehabilitation (ICR) Give
Impact after Cardiac Surgery in Kelantan, Malaysia
M ZAKIRA, G MOHAMAD ZIYADI, A MOHAMED RUSLI, LA KHATIJAH
University of Sciences Malaysia, Malaysia
Health education in Intensive cardiac rehabilitation is an effective program
to improve quality of life for patients after cardiac surgery. In developing
countries cardiovascular disease still a main cause of death and quality of
life patients is low compare with others country. This pilot study was
conducted in HUSM using non rondomised control trial design to evaluate
the quality of life of cardiac surgery patients after an intensive cardiac
rehabilitation programme. A total of 30 patients with cardiac problems
admitted to Coronary Intensive Care Unit (CICU) and planned for cardiac
surgery was assigned into control (group A) n=15, and experimental (group
B) n=15 groups. Participants in group A were using Intensive Cardiac
Rehabilitation (ICR) module A (HUSM) whereas group B was using module
B(IREKAF). Quality of life (QOL) was measured four times (pre-test, phase
1, phase 2 and phase 3) using self-administered questionnaire generic
SF 36. The repeated measure ANOVA were used to analyse the difference in
score of QOL among group A and B and the time effect of QOL when patient
following ICR. The results showed that group B score higher than group A
for SF 36 (p<0.05). The time effect for SF 36 showed that there was only
one pair (t1 and t0) for which there were no significant difference with
p-value >alpha 0.05. The differences for all the other pair were significant
at p<0.05. Group B was higher time effect compare with group A. In
conclusion, findings of this pilot study indicated that ICR module B was
better than ICR module A in improving QOL of patients after cardiac surgery.
It is recommended that an evaluation of QOL should be done after 12 weeks
of cardiac rehabilitation programme.

6.
Tai Chi as an Alternative Cardiac Rehabilitation 'Warm up'
Exercise
M KOLARIK, C NEWTON
Southern Health, Victoria, Australia/Clayton Community Rehabilitation
Centre, Australia
Objective: Incorporate Shibashi (18 movements) Tai Chi style 'warm up'
exercise into the Cardiac Rehabilitation Program (CRP). Add variety,
stimulate client interest and encourage on going participation on discharge.
Evaluate Tai Chi as a viable alternative to conventional exercise.
Background: Southern Health (SH) is the largest healthcare provider in
Melbourne, Victoria. Recent standardization of CRP delivery in Community
Rehabilitation Centers (CRC) resulted in the current 7 session weekly
outpatient program including 1 hour of physical exercise and cardiac
education respectively. In 2009 a systematic review of Tai Chi exercise for
patients with cardiovascular conditions and risk factors was published. It
concluded there is evidence that Tai Chi exercise may be a beneficial
adjunctive therapy. In 2009 and 2011, 2 posters titled Cardiac Chi and Tai
Chi as an alternative cardiac rehabilitation 'warm up' exercise were
presented at the annual Victorian Association Cardiac Rehabilitation (VACR)
Conference.
Method: The CRP Quality Project commenced in 2010. Staff introduced a
10 minute Shibashi Tai Chi 'warm up' that alternated every 3 weeks with
conventional exercise. The 22 clients surveyed, all practiced and then
compared both styles. On discharge they all completed a 5 question
evaluation survey.
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Results: (T=21 clients)
• 100% of clients agreed that Tai Chi was an effective 'warm up' in
preparation for cardiac rehabilitation exercise
• 100% of clients agreed they could comfortably and effectively participate
in Tai Chi
• 75% of clients preferred Tai Chi over conventional exercise
• 76% of clients did not use Tai Chi as a warm up exercise at home
• 62% of clients will consider taking up regular Tai Chi exercise
Conclusion: Tai Chi 'warm up' was incorporated into the CRP in October
2011 and is a viable alternative to conventional exercise. It is safe, suitable
for all ages, flexible in delivery and enjoyable for clients. Further research
is required to ascertain whether regular Tai Chi exercise has cardiac health
benefits after discharge.
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Cardiac Rehabilitation Program in Private Practice in Hong Kong
AWS LEUNG, GYK MAK, CTH CHOW, SSW LAM, TMF LIU, DWH LUI,
AWF TAM
PRO-CARDIO Heart Disease & Stroke Prevention Centre, Hong Kong
Introduction: In Hong Kong, structured cardiac rehabilitation (CR) programs
have been developed since the 1990's. Surveys on the CR service in Hong
Kong were conducted in 2002 and 2005, showing that phases I and II services
were provided mainly in the public hospital system, while the communitybased phases III and IV services were provided by non-government
organizations or patient self-help groups. There was CR program in one of
the private hospitals, and most private cardiologists had considered it useful.
Objective: To set up a clinic-based structured CR program in private sector
in Hong Kong, to analyze the similarities to and differences from those of
public sector, and to evaluate on the current status.
Results: The program was introduced in June 2011, and fully implemented
in November 2011, as a clinic-based phase II service. It is recommended
mainly for patients with heart attack (post-AMI), heart failure, or after
interventional procedures. Service providers include a nurse, a dietitian and
a physical trainer, with cardiologists as organizers and supporters.
Participants can choose an either 4-week or 8-week program, which is either
individual- or group-based. Each participant attends 1 session per week. A
30-minute consultation is given in every session, which covers drug
knowledge, nutrition therapy, psycho-social counseling, and smoke
cessation. Exercise capacity is assessed through treadmill test, and exercise
therapy is prescribed by a cardiologist according to the result. Exercise

training is carried out for 45-60 minutes in each session by the physical
trainer. Program extension for an extra 4-8 weeks will be considered if
appropriate. Progress on participants was monitored by evaluating
improvement in quality of life (QOL). Since the program was started, 25
participants had been recruited (19 males and 6 females). Twenty-three were
post-PCI (including 4 AMI) cases, 1 heart failure and 1 valve replacement.
Ten patients attended 8-weeks program, while 15 attended 4-week program.
QOL evaluation was done for 10 participants, and 7 of them showed
improvement.
Conclusion: This study illustrated the implementation of a structured phase
II cardiac rehabilitation program in a private clinic in Hong Kong. Owe to
the fundamental differences from the public setting, there are diversities
from the public counterpart in the logistic, design and workflow of the
program. Twenty-five participants had joined the program, and their
responses were positive and encouraging. Further program review and
evaluation will be accomplished.

8.
Measurement of the Effectiveness of Structured Education
Interventions for Cardiac Rehabilitation Participants
M MCANDREW, M BALES, S BARTLETT, J GRICE, R WILLIAMS,
S WOODRUFFE
Ipswich Cardiac Rehabilitation Service, Australia
Introduction: The Ipswich Cardiac Rehabilitation Service provides a sixweek Phase Two exercise and education program. The heart health education
program is provided via up to twelve; 60 minute education sessions or a
Fast Track education day (6.5 hours). Each participant is also provided
individual risk factor modification education, advice and counseling. This
is delivered via the use of clinical pathways, patient questionnaires, one-toone discussions and referral to allied health specialists. An evaluation tool
was developed to measure the effectiveness of the educational program on
participant's heart health knowledge.
Methods: This tool was provided to participants at their first presentation
to our Service and at the completion of their program. The tool assessed
knowledge of general and individual lifestyle factors that contribute to poor
heart health, medication awareness, ideal levels for lipids and blood pressure
measures, use of alcohol, managing emotional well-being and recommended
exercise intensity.
During the period from January 2011 to May 2012; 277 pre and 205 post
questionnaires were collected. Data from these completed tools were collated
and analysed.
Results: Poor diet (pre 67%, post 80%), inactivity (pre 60%, post 64%) and
smoking (pre 48%, post 62%) were most often selected to contribute to
poor heart health. The inverse of these factors were chosen most often to
improve heart health: Physical activity (pre 79%, post 90%), Good diet (pre
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74%, post 90%) and QUIT smoking (pre 21%, post 28%) . Pre program,
less than half of participants selected HDL as the "Good" cholesterol. This
measure increased from 41% to 78% of completers. Awareness of Heart
Foundation Australia recommended levels for lipids increased in the order
of 24-35% of completers. Assessments of exercise intensity, "Lightly puffing"
(30% increase) and RPE 3-4 (15% increase) proves that participants are
more aware of recommended exercise intensity levels at completion of their
program.
Summary: There seems to be the opportunity during phase two cardiac
rehabilitation to enhance the effectiveness of traditional education sessions
via the use of clinical pathways and a structured approach to interventions
tailored to individual patient needs. Implementation of this questionnaire
tool provided the opportunity to address individual patient knowledge gaps.
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Influence on the Restenosis Rate of Early Introduction of Cardiac
Rehabilitation after Percutaneous Coronary Intervention
J IWASAKA, T TAKAHASHI, M KUBOTA, Y IHARADA, H OTANI,
T IWASAKA, I SHIOJIMA, Y KIMURA
Department of Internal Medicine II, Kansai Medical University, Japan
Background: Though devices of percutaneous coronary intervention (PCI)
such as drug eluting stent (DES) has been markedly developed, the problem
of restenosis is still remained.
Objectives: We assessed protocol of early introduction of cardiac
rehabilitation after PCI adopted in middle 2010 in our hospital.
Methods: We assessed the 29 cases performed PCI and enrolled our cardiac
rehabilitation program from 2009 to 2011. Thirteen patients were enrolled
to old program, which started 30 days after PCI. Sixteen were enrolled to
new program, which started low-grade exercise next day of PCI and star
regular exercise 40 days after PCI.
Results: Restenosis was found in 5 cases in old program group and 3 cases
in new program group. Three patients were suffered from restenosis with
DES in old program group (3/7), indeed no restenosis was found in patients
with DES in new program group. No significant differences were found in
blood pressure and lipid profiles.
Conclusion: Early introduction of cardiac rehabilitation after PCI may lead
the reduction of restenosis ratio even in DES era.

10.
Psychological Correlates of Stage of Readiness to Quit Among
Hong Kong Chinese Smokers: The Role of Social Acceptance of
Smoking by Family and Friends
DYP LEUNG, EML WONG, SY CHAIR
The Nethersole School of Nursing, The Chinese University of Hong Kong,
Hong Kong
Objective: The Attitude-Social Influence-Efficacy (ASE) model was
developed from the Theory of Reasoned Action and Bandura's Social
Cognitive Theory together with the Transtheoretical models have been used
to gain insight into the determinants and guide the development of
interventions for smoking cessation. Yet, no study has reported the impacts
of ASE constructs on the readiness to quit of Hong Kong smokers in one
study. This study thus aims to explore the associations between ASE
constructs and readiness to quit smoking among Hong Kong Chinese
smokers.
Methods: A cross-sectional study design was employed. Hong Kong
residents who aged over 15 years old and smoked at least 1 cigarette in a
week in the past 6 months were recruited via advertisements and nongovernment organizations from February to December 2010. Participants
completed a baseline questionnaire including psychological constructs in
the ASE model including attitudes of quitting smoking, self-efficacy too
resist smoking, social norm, social support of quitting, and social acceptance
of smoking from family and friends, and priority of quitting. Multivariate
analysis (MANOVA) was used to contrast differences of ASE constructs
across the four stages of readiness to quit smoking.
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Results: A total of 309 participants were recruited and 289 (93.5%) provided
completed responses in ASE constructs and stage of readiness to quit. Their
mean age was 27.6±12.4 years, 49.8% were male, 76.4% were married and
69.9% had education level of secondary 4-5 or above. Among them, 71.5%
(n=213) were in the pre-contemplation, 7.7% (n=23) in the contemplation,
6.7% (n=20) in the preparation and 14.1% (n=42) in the action stage. MANOVA
showed that there were statistically significant differences in the mean scores
of social support (F=3.140, p=0.026), self-efficacy to resist smoking due to
internal (F=2.767, p=0.042) and external stimuli (F=3.258, p=0.022), social
acceptance of smoking by family (F=7.506, p<0.001) and friends (F=4.316,
p=0.005) by stage of readiness to quit. Tukey's pair-wise comparisons showed
that participants in the precontemplation stage had significantly lower mean
scores than those in the action stage in self-efficacy to resist smoking due to
internal (2.73±0.07 vs 3.21±0.16) and external stimuli (2.86±0.08 vs 3.41±
0.17), and reported higher acceptance of smoking than those in the preparation
and action stages by family (PC:2.77±0.12, P:1.25±0.40, A:1.91±0.28) and
friends (PC:3.80±0.11, P: 2.78±0.37, A:3.06±0.25).
Conclusion: The results of higher acceptance of smoking by family and
friends among precontemplators highlight that social influence from smokers'
living circles may play an important role in their readiness to quit smoking.
While current smoking cessation programmes focus mainly on enhancing
self-efficacy to resist smoking, future development in cessation interventions
can also include smokers' family members and friends by stopping the
smokers to smoke around them.
Acknowledgement: The study was funded by the Seed Funding for Applied
Research, the University of Hong Kong to Doris Y.P. Leung.
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Rates of Attendance at a Smoking Cessation Clinic within a
Cardiac Rehabilitation Service
P CAMP, C-J(JO) WU, W SENIOR
Cardiology Department, Mater Adult Hospital, Australia
Objectives: Smoking cessation has been shown to be an important
intervention for preventing cardiovascular events and improving the health
of patients with heart disease. However, unaided quit attempts in these
patients often leads to high rates of failure and a return to smoking. Outpatient
smoking cessation clinics using face-to-face counseling, ongoing behavioral
support, advice on smoking pharmacotherapy and objective monitoring, have
been found to be one of the most effective interventions for improving quit
smoking rates. An outpatient smoking cessation clinic was trialed within a
cardiac rehabilitation service in order to explore its effects on smoking rates
for patients with or at risk of heart disease. Attendance rates to the clinic
were also monitored.
Methods: A descriptive exploratory design was used for this newly developed
clinic. Patients who currently smoked tobacco and who had a history of
either coronary artery disease, heart failure, atrial fibrillation or those seen
under a chest pain assessment service were invited to an outpatient 'Cardiac
Patients Smokers Clinic'. Initially patients were offered up to 10 clinic visits
over a 3 month period. Follow-up clinic visits were conducted at 3, 6 and 12
months. A portable carbon monoxide meter was used to objectively measure
levels of smoking and validate smoking abstinence. Primary outcomes
included rates of attendance.
Results: Preliminary findings showed 24 per cent of participants (N=6)
completed all their clinic visits and remained smoke free as measured by
their ongoing expired carbon monoxide readings. Clinic attendance rates

appeared lowest for those with significant mental health issues such as
schizophrenia or substance abuse. However, rates of attendance were
improved by having an administration officer make reminder telephone calls
prior to clinic visits.
Conclusions: Early findings indicate the feasibility of providing a specialist
smoking cessation clinic within a cardiac rehabilitation service. Further,
that reminder telephone calls prior to appointments improved attendance
rates in patients with heart disease to this type of clinic. However, future
investigations are warranted.

12.
Obesity Is a Major Risk Factor for Other Cardiovascular Risk
Factors
S TAHEREH,1 Z AMIR,2 S MAHMOOD,1 G AAZAM2
1
Tehran University of Medical Sciences, Nursing and Midwifery Faculty,
Ph.D. Students Department, Tehran; 2Metabolic Diseases Research Center,
Qazvin University of Medical Sciences, Qazvin, Iran
Background: Obesity is the major risk factor for cardiovascular diseases.
Nevertheless, there are no studies concerning the relationship between
degrees of obesity with cardiovascular risk factors among Iranian population.
Objective: This study aimed to investigate the relationship between the degree
of obesity and risk factors of cardiovascular diseases including hypertension,
dyslipidemia, diabetes mellitus and smoking.
Methods: This is a cross-sectional and correlational study, which carried
out on 1100 male and female individuals in Qazvin, a city in center of Iran,
from September 2010 to February 2011. Study population was selected
through a randomized cluster sampling method. Then a general physician
implemented physical examination (medical history, blood pressure, BMI)
using a structured interview. In addition, anthropometric characteristics and
serum biochemistry tests (including FBS, GCT-2h, HDL-C, LDL-C,
Cholesterol and TG) were measured as well. Data were analyzed using SPSS
19, descriptive and analytic statistics. The statistical tests were significant
at P<0.05.
Results: Data related to BMI categories demonstrated overweight (40.9%),
obesity (17.0%) and central obesity (24.8%) among studied participants. In
addition, the frequency of high level LDL-C, hypercholesterolemia,
hypertriglyceridemia, Diabetes, and high level of GCT-2h were measured
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43.3%, 46.6%, 51.8%, 31.0%, 51.8%, respectively. Furthermore, 24% of
women and 32.1% of men were in pre-hypertension stage and 8% of women
and 16.1% of men had hypertension. In obese men and women, odds ratio
for hypertension was 3.39 and 4.41, respectively. In addition, this ratio for
women was more than men considering cholesterol disorders (men=1.95,
CI=1.33 to 2.87, women=2.45, CI=1.60 to 3.75). Lastly, for diabetes, it was
2.28 and 3.73 among obese men and women, respectively.
Conclusions: In general, obesity in all levels had a significant relationship
with other cardiovascular risk factors. Interventions to reduce obesity and
weight regulation programs might have large effects on development of risk
factors of cardiovascular diseases.
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13.
Creative Fruity Venture − Finds Its Way to Promote Fruit
Consumption Among Secondary Students
KH KUNG, YK LUK, AMC SO, AYC FU, PTH KO, RCT CHING
Department of Health, Central Health Education Unit, Hong Kong
Background and Objectives: The World Health Organization recommends
consumption of at least five servings of fruit and vegetables daily for
prevention of chronic diseases including cardiovascular diseases. In Hong
Kong, only 15% of children aged 11-14 eat an adequate amount (at least 2
servings) of fruit per day. The Department of Health has been organising
the "Creative Fruity Venture" (CFV) since 2010 to promote fruit eating among
secondary students. CFV involved teacher-led and student-based activities
in the design and implementation of fruit promotion activities. A total of
162 secondary schools with some 128,000 students joined CFV in the 2011/
12 school year, and various game booth activities, fruit parties, fruit
distribution occasions, cooking events and other fruit promotional activities
were held. The Hong Kong College of Cardiology provided 49 schools with
funding support of up to $2,000 each. A survey was conducted to assess the
effectiveness of CFV.
Methods: Between 6 January and 12 June 2012, students from two randomly
selected classes from 44 schools were asked to complete a set of pre-event
and post-event questionnaires. Questions on fruit preference, fruit eating
behaviour and school-based fruit promotional activities were included.
Results: A total of 2,779 pre-event and 2,705 post-event questionnaires were
collected with response rates reaching 94% and 92% respectively. CFV
promotional materials were noticed by 40% of surveyed students, with 75%
finding them attractive. About half of surveyed students participated in
school-based fruit promotional activities, and most reported such activities

had increased their knowledge of fruit (76%), aroused their interest in fruit
eating (81%) and increased their fruit consumption (62%). More students
surveyed one week after the event perceived their schoolmates liked fruit
(post-event 62% vs pre-event 49%; p<0.001) and had brought fruit from
home for consumption (post-event 14% vs pre-event 7%; p<0.001). About
80% of students hoped to join CFV again in the next school year.
Conclusion: CFV was effective and should be considered as a regular event
to promote fruit eating among secondary students.

14.
Out-Patient Cardiac Rehabilitation Program (CRP) for Patients
After Left Ventricular Assisted Device (LVAD) − First Experience
in Hong Kong
K FAN,1 J NG,2 KY CHENG,1 KYP CHAN,1 J LI,2 KL LEUNG,3 KW LAI,1
KW SIT,1 E WONG,4 SL LAM,5 RWC LI,5 CKL HO,5 WK AU5
1
Cardiac Medical Unit, 2Physiotherapy, 3Occupational Therapy, 4Dietetic
Departments; Grantham Hospital; 5Cardiothoracic Surgery Department,
Queen Mary Hospital, Hong Kong
Introduction: LVAD is increasingly being accepted as mechanical
circulatory support for patient with end-stage systolic heart failure as bridgeto-transplant. The newer LVAD has been established for long-term support
as outpatient (outside surgical intensive setting) and the main determinant
of outcome is exercise capacity. We report our first experience of setting up
a multidisciplinary CRP in Hong Kong. All team members received structured
training in long-term management of LVAD. Protocols were set and agreed
between all teams in Grantham Hospital (GH) and Queen Mary Hospital
(QMH).
Case Report: Mr T is a 51-year-old man with end-stage heart failure secondary
to idiopathic dilated cardiomyopathy. He received LVAD (HeartMate II,
Thoractec, USA) implantation in QMH in December 2011. Early mobilization
was commenced while as in-patient during post-operative period. He started
the CRP in GH in March 2012. The biweekly multidisciplinary CRP consists
of aerobic exercise training on treadmill, light resistance weight lifting exercise
for lower limbs muscles, dietary counseling, psychosocial support with
emphasis on self management.
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Outcome: The patient completed 10 sessions of gradual aerobic exercise
training and 2 sessions of weight lifting exercise. The pump parameters
remained stable and mean blood pressure increased slightly from 72 to
85 mmHg during exercise. From March till August 2012, the exercise
tolerance improved with treadmill speed increased from 1.7 to 2.2 mph @ 0%
gradient (duration increased from 10 to 20 mins). The 6-MWT was decreased
slightly but did not reach significance. There was a slight increase on
depression score during early phase with lower self-efficacy on emotional
control with the feeling of being overwhelmed with the VAD regime
responsibility. Quality of life scores improved slightly especially on physical
function (from 30 to 55) with higher self-efficacy on stairs climbing (from 0
to 80). Physical active lifestyle established with optimal exercise habit (from
85 to 210 mins/week).
Conclusion: This case illustrated that a well designed multidisciplinary CRP
for LVAD patients is important with improving exercise tolerance. The need
for intense psychosocial support is important for the well being of the patient.
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Cardiac Rehabilitation Program: Beginning of a New Life Style
Revamp
FCC TAM, WS CHAN, LSW LI, YY HO, KB LAM, I TAM, S WONG,
R WONG, T CHU, L LAM, RHW CHAN, SWL LEE
Queen Mary Hospital, Hong Kong
Mr KLK is a 69-year old businessman and a renowned musician specialized
in flute (
). He has history of hypertension, hyperlipidemia and
obstructive sleep apnoea. He presented in 1/2009 with acute anterior ST
elevation myocardial infarction (STEMI) and given streptokinase with
subsequent percutaneous coronary intervention (PCI) to left anterior
descending artery (LAD) done. However, he suffered from haemopericardium
and cardiac tamponade the day after PCI. The clinical course was stormy
and finally he recovered and transferred to Tung Wah Hospital cardiac
rehabilitation unit in 2/2009. Upon recruitment to the cardiac rehabilitation
program (CRP), he had poor functional status and found difficulty to resume
his work and enjoyed his leisure activity. He acknowledged the importance
of stamina and cardiopulmonary fitness in playing flute which requires a lot
of Valsalva maneurve. He had contemplated to give up his interest. Through
4 phases of CRP, he gradually showed improvement in clinical parameters
(NYHA class, echocardiography), exercise capacity (treadmill exercise test),
risk factor control (lipid profile, glucose, exercise habit) and psychological
well-being (SF36 score). Now he has resumed his work as a businessman
and continued to participate in various musical activities as teacher, conductor
and performer. Our CRP staff was delighted to attend the Chinese
instrumental concert held in Hong Kong City Hall in 4/2012.

16.
Can Participation in 4 Weeks Phase II Cardiac Rehabilitation
Program (CRP) Improve Fitness and Functional Capacity?
A AHMAD
Department of Physiotherapy & Rehabilitation, National Heart Institute,
Kuala Lumpur, Malaysia
Background: The positive effect of physical activity on coronary artery
disease has long been shown, as has the positive effect of participation in 1
month Phase II Cardiac Rehabilitation Program (CRP).
Aim: The aim of this study was to ascertain the level of improvement of
fitness over Phase II CRP and to see what type of patients from a fitness
point of view benefited most from participation in CRP.
Method: Retrospective descriptive study from (April to July 2012), of
patients who participated in 1 month (twice a week) Phase II CRP. Each
patient undertakes a pre assessment which includes; physical assessment,
current cardiac status, lifestyle assessment, agreed goals and 6-minute walk
test (6-MWT). The 6-MWT was used in the program for both pre and post
Phase II CRP. During the program, the Maximum Heart Rate method was
used to calculate target heart rate and exercise prescription was set a
maximum of ≤75%. The results of the 6-MWT were converted to estimated
MET's for analysis.
Results: The sample number was 42, which was made up of 35 males and
7 females. Paired t-test was use for this analysis. The average age was
54.88±8.74 years. The P values between estimated MET's level achieved
pre Phase II cardiac rehabilitation program, and post program was P<0.001
significant. Pre assessment results gave a mean 6-MWT, 432.38±85.45 meter
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and mean estimated MET's was 4.04±1.31. After 4 weeks of structured
exercise program, the 6-MWT was 530.95±73.41 meter and mean estimated
MET's was 4.64±1.29. This indicated that all of the patients for this study
are still classified as sedentary (MET's ≤10 ACSM 2001). Post cardiothoracic
patients showed greater improvement as compared to cardiology in their 6MWT distance (111.9 meter, 30.6%) while only one patient do not improve.
Conclusion: Distance from 6-MWT increased significantly as a consequence
of 1 month Phase II CRP in both cardiology and cardiothoracic patients.
However all of the patients are classified as sedentary from a fitness point of
view post Phase II CRP. Is this improvement enough to reduce risk? Is the
program sufficient enough or should the setting of exercise prescription goals
set higher than the current guidelines?
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Improvement in Exercise Tolerance in Patients with a Cutest
Elevation Myocardial Infarction Received Primary Percutaneous
Coronary Intervention after Cardiac Rehabilitation in Hong
Kong − A Single Center Experience
SWL LEE, FCC TAM, LSW LI, WS CHAN, TK KWOK, MKL WONG,
AYT WONG, ASY YUNG, KB LAM, YY HO, SY CHIU, I TAM, S WONG,
R WONG, T CHU, L LAM, RHW CHAN
Queen Mary Hospital, Hong Kong
Objectives: The management of acute ST elevation myocardial infarction
(STEMI) in Hong Kong is shifting from giving thrombolytic agents to
performing primary percutaneous coronary intervention (PCI). However,
local data concerning patients after primary PCI is sparse and we aim to
evaluate the outcome after cardiac rehabilitation in this group of patients.
Methods: This is a single center, retrospective analysis. All patients suffered
from STEMI with primary PCI done in Queen Mary Hospital were considered
to be referred to join the cardiac rehabilitation program (CRP). Data was
retrieved from the primary PCI registry and outcome parameters concerning
exercise capacity such as New York Heart Association (NYHA) class, six
minute walk distance and treadmill exercise test were gathered at baseline,
after Phase 2 (twice weekly exercise program lasting for 8 weeks) and Phase
3 (community-based home exercise program lasting for 6 months) of the
CRP.
Results: From 2006 to 2010, there were 234 STEMI patients with primary
PCI performed and 158 were enrolled to the CRP. Excluding 22 patients
with in-hospital death, the enrollment rate is 74.5%. After Phase 3 of the
program, 67% of patients had improvement in NYHA class symptoms. For
six minute walk test, the walking distance was significantly improved

(Baseline: 417±112m, Phase 2: 475±114m, Phase 3: 476±111m, Baseline
vs. Phase 2: p<0.001; Baseline vs. Phase 3: p<0.001). For treadmill exercise
test, there were significant improvement in metabolic equivalents (METS)
achieved and exercise time (Baseline: 6.7±3.2METS, 10.3±4.4 minutes;
Phase 2: 9.0±3.2METS, 13.2±3.7 minutes; Phase 3: 9.1±3.4METS, 13.3±
3.7 minutes, Baseline vs. Phase 2: p<0.001; Baseline vs. Phase 3: p<0.001).
Conclusion: Cardiac rehabilitation improves symptoms and exercise capacity
in patients with STEMI received primary PCI. Structured cardiac
rehabilitation program should be incorporated into routine long term clinical
management of this enlarging group of patients in Hong Kong.

18.
Determinants for Achieving the LDL-C Target of Lipid Control
for Secondary Prevention of Cardiovascular Events in Taiwan
CC WU,1,2 WH YIN,3,4 JW CHEN,5,6 ON BEHALF OF THE TAIWANESE
SECONDARY PREVENTION FOR PATIENTS WITH ATHEROSCLEROTIC
DISEASE (T-SPARCLE) REGISTRY INVESTIGATORS
1
Division of Cardiology, Department of Internal Medicine, National Taiwan
University Hospital, 2Department of Primary Care Medicine, College of
Medicine, National Taiwan University, 3Division of Cardiology, Heart
Centre, Cheng-Hsin General Hospital, 4Faculty of Medicine; 5Institute of
Pharmacology, School of Medicine, National Yang-Ming University;
6
Department of Medical Research and Education, Taipei Veterans General
Hospital, Taipei, Taiwan
Background: Epidemiological and clinical studies have clearly established
the link between low-density lipoprotein cholesterol (LDL-C) and
atherosclerosis-related cardiovascular consequences. All treatment guidelines
developed in different countries identify LDL-C as a causative factor for
cardiovascular disease and as a target for lipid-lowering therapy. Although
it has been a common practice for physicians to prescribe lipid-lowering
therapy for patients with dyslipidemia, the achievement rate is still not
satisfied in Taiwan. Therefore, the determinants for achieving the LDL-C
target needed to be clarified for better healthcare of the patients with
dyslipidemia.
Method: This registry-type prospective observational study enrolled the
patients from 18 medical centers across Taiwan, and clinically followed them
for five years. At every clinical visit, vital signs, clinical endpoints, adverse

J HK Coll Cardiol, Vol 20 (Suppl 2)

events, concurrent medications and laboratory specimens were obtained as
thoroughly as possible. The lipid profile (total cholesterol, HDL-C, LDL-C,
TG), liver enzymes, and creatinine phosphokinase were evaluated at baseline,
and every year thereafter. The cross sectional observational data was analyzed
for this report.
Result: Among the 3486 registered patients, 54% had their LDL-C
<100 mg/dL. By univariate analysis, the patients achieving the LDL-C target
were associated with older age, more male sex, taller height, lower blood
pressure, more under lipid-lowering therapy, more smoking cessation, more
history of CAD, DM, physical activity, but less history of stroke or TIA.
The multivariate analysis showed statin therapy was the most significant
independent determinant for achieving the treatment target, followed by
age, history of CAD, DM, blood pressure, and sex.
Conclusion: Recently, 54% of the patients with CVD have achieved their
LDL-C target in Taiwan, and the most significant determinant for this was
statin therapy.
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Supervised and Individualized Exercise Training Increase the
Exercise Compliance of the Patients with Myocardial Infarction
K MADAN, A AGARWAL, AK JARYAL, JPS SAWHNEY, KK DEEPAK
Dharma Vira Heart center, Sir Ganga Ram Hospital, India
Objectives: The present study was done to evaluate the effect of supervised
and individualized exercise training over 14 days in patients of first
myocardial infarction on the duration of conditioning period.
Methods: 21 patients (age 48.66±7.19 years, all males) presenting with first
myocardial infarction were selected. The TMT was done 14 days after the
index event and was repeated after 2 weeks after the exercise training. Six
session of supervised training was done. For each patient, the grade of
exercise training was set according to pre-training MET as per the ACSM
guidelines. The duration of conditioning period during each session of
exercise training was limited by rate of perceived exertion (Borg Scale, cut
off = 13). The duration of conditioning period, maximum heart rate and
maximum systolic blood pressure were noted.
Results: There was significant increase in the duration of patient limited
conditioning period. This was evident at each session where the conditioning
period was more than previous session. The maximum heart rate and systolic
blood pressure during training did not show any change during the 6 sessions.
The post training MET during TMT were significantly increased as compared
to pre-training METS (10.63±1.47 vs 8.62±1.89; p=0.00005).
Exercise session

1

2

Duration of
conditioning
period (in min)

7.93±3.38

10.70±3.23 12.58±3.77 15.26±3.47 16.97±4.27 18.23±5.02

P value (between the
consecutive sessions)

0.00001

3

0.0005

4

0.0001

5

0.005

Conclusion: Each session of supervised and individualized exercise training
leads to increase in the duration for conditioning period. Within 2 weeks
the average increase in the duration was 10.3 minutes (2.3 times). This change
was not accompanied with any decrease in the maximum heart rate or systolic
blood pressure. In-hospital supervised training can be used to increase the
exercise compliance of the patients as part of management of myocardial
infarction.

6

0.00009

20.
Rehabilitation Companion System for Phase III&IV Cardiac
Rehabilitation
TH LU, RR CHEN, YH LEE, BR WU
Service Systems Technology Center, Industrial Technology Research
Institute, Chutung, Hsinchu, Taiwan
Industrial Technology Research Institute (ITRI) has designed a rehabilitation
companion system to provide cardiac patients a series of scientifically proven
exercise programs (e.g., 3-minute step test and Taichi), based on use of
computer gaming and motion sensor technologies. This system can
automatically monitor and guide an outpatient's rehabilitation exercise, as
characterized by body flexibility, muscle strength and endurance,
cardiopulmonary endurance as well as other physical fitness factors. The
system can also generate optimal instructional menus based on interaction
with a virtual therapist. The virtual therapist can determine the accuracy of
body movement by comparing the standard skeleton of the virtual therapist
and the user skeleton in real-time trace, allowing for guiding patients how
to adjust their body movement. Therefore, cardiac patients can perform
rehabilitation exercise safely and comfortably in this home-based virtual
gaming-environment that the rehabilitation companion system provides in
order to increase compliance with their physicians' prescribed exercise
regime.
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Effect of Structured Teaching Program on Nutritional Habits of
Hospitalized Angina Pectoris Patients
A SHAHROKHI, A GHORBANI
Qazvin University of Medical Sciences (QUMS), Iran
Introduction: Angina Pectoris (AP) in coronary heart diseases (CHD) can
be prevented or reduced through modifying diet-related risk factors like
serum level of cholesterol, triglyceride and glucose.
Objective: To investigate the effect of a structured teaching program on AP
patients' nutritional habits in Ave-Sina teaching hospital in Qazvin, Iran.
Method and Material: In a quasi-experimental study (before-after), 21
patients between the ages 35-65 (who had been hospitalized due to unstable
AP) were recruited. All participants signed an informed consent, then they
participated in 30-45 minutes face to face instructional session about healthy
diet and proper habits. After the session all patients were given a related
pamphlet. By a questionnaire, Before teaching program and after 3 months,
patients' knowledge and performance regard to healthy nutritional habits
were assessed. Data was analyzed by T-test and squared Chi. Value of
P<0.05 was considered for significant differences.
Findings: Of 21 patients; 11 (52.4%) were male and 10 (47.6%) female.
The most participants (38.1%) were between 51-60 years old and low literate
(56%). Sixty-six percent of patients didn't already have history of angina
pectoris. Based on pretest scores, most patients' knowledge and performance
was moderate (76.2%) and only 9.5% had good knowledge and performance.
After 3 months most of them had good (47%) and moderate (52.4%)
knowledge and performance. Analysis showed significant statistical
difference between their knowledge and performance before and after
structured teaching program (P=0.000). No significant relation was seen

between knowledge and performance of patients with their demographic
characteristics.
Conclusion: The results of the study confirm on the importance of structured
teaching programs as one of the most important roles of health care team
(particularly nurses) that is necessary to prevent and control patients' signs
and symptoms.

22.
Factors Influencing Health-Related Quality of Life in Hong Kong
Chinese Patients with Implantable Cardioverter Defibrillator
(ICD)
FMF WONG
The Chinese University of Hong Kong, Hong Kong
Background: Sudden cardiac death (SCD) attributed to lethal ventricular
arrhythmias is one of the major causes of death in Hong Kong and worldwide.
To reduce mortality in patients at risk, implantable cardioverter defibrillator
(ICD) has become the favorable treatment. However, it may influence healthrelated quality of life (HRQOL). Factors influencing HRQOL outcomes of
ICD population are still unclear. Understanding factors helps develop
appropriate protocols and intervention for reducing negative factors and
strengthening positive factors so as to improve current ICD patient care.
Purpose: To explore associating factors related to patients' characteristics
influencing HRQOL outcomes in ICD patients
Methods: A cross-sectional correlational design was employed. A convenient
sample of 139 adults with ICD implantation were recruited in the out-patient
clinic at two large medical teaching hospitals in Hong Kong between from
January 4 to April 30, 2012. Survey package containing demographic and
clinical data form, Chinese (Hong Kong) version of SF-36, HADS, and SSQ6
were asked through face-to-face interview in outpatient clinics at two public
hospitals in Hong Kong.
Results: Of 139 ICD patients, 107 (77.0%) were men and 32 (23.0%) were
female. The mean age was 63.0±14.6 years ranging from 18 to 88 years.
The SF-36 result revealed that physical functioning is relatively lower than
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mental health and social functioning although they all presented with higher
score (mean >70). The associating factors including demographic factors
(age, gender, living status, dependence, educational level), clinical factors
heart failure (HF), hypertension (HT), atrial fibrillation (AF), diabetes
mellitus (DM), ICD related factors (type, time interval, frequency of ICD
implanted and ICD shock experience and psychological factors (depression,
and anxiety), were significantly influencing specific HRQOL subscales.
Depression was the most significant associating factors influencing all
HRQOL subscales except bodily pain.
Conclusion: The findings provide evidence of various demographic, clinical,
ICD related and psychological factors may influence HRQOL in Chinese
ICD patients in Hong Kong. The results suggest that early screening for atrisk patients, particularly depressive patients, for initial prevention and
referrals is highly desirable.
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Atrial Fibrillation and Early Outcomes after Mitral Valve
Replacement in Patients with Rheumatic vs. Non-Rheumatic
Mitral Stenosis
SJ MIRHOSSEINI, 1 SAH SAYEGH, 2 MH ZADEH, 1 N NADERI, 3 SMY
MOSTAFAVI POUR MANSHADI1
1
Department of Cardiac Surgery; 2Yazd Cardiovascular Researches Center,
Afshar Hospital, Shahid Sadoughi University of Medical Sciences; 3Member
of Research Group of Shahid Sadoughi University of Medical Science and
Ali ben Abitaleb Medical College (Islamic Azad University), Yazd, Iran
Background: Atrial fibrillation (AF) is the most common arrhythmia after
open heart surgery that can lead to early morbidity and mortality following
operation. Mitral stenosis (MS) is a structural abnormality of the mitral valve
apparatus that can result from previous rheumatic fever or non-rheumatic
fever such as congenital mitral stenosis, malignant carcinoid disease and
etc. This study was designed to test the hypothesis that type of mitral stenosis
can affect on post-Mitral valve replacement incidence, duration and
frequency of AF and early complications in patients undergoing mitral valve
replacement.
Material and Method: We selected 50 patients with rheumatic mitral
stenosis and 50 patients with non-rheumatic mitral stenosis candidate for
mitral valve replacement surgery. Preoperative tests such as; CRP, ESR,
CBC, UA, ANA, APL, ANCA, RF, IgM, IgG were performed on participant's
samples and clinically suspected for determination of type of mitral stenosis,
rheumatic or non rheumatic. The demographic variables and early
postoperative complications such as infection, bleeding, vomiting, heart

failure, renal and respiratory dysfunction, ICU and hospital stay and
echocardiography findings were recorded. All patients underwent holter
monitoring after being out of ICU to the time of discharge.
Results: 57 cases (57%) were male and 43 cases (43%) were female. Post
operative AF occurred in 14 cases (14%); 3 cases (6%) related to nonrheumatic mitral stenosis group and 11 cases (22%) related to the rheumatic
mitral stenosis group. There was a significant relationship between incidence
of AF and type of mitral stenosis (p=0.02). Post-MVR bleeding was lower
in rheumatic MS rather than non-rheumatic MS (p=0.4). Renal dysfunction
after MVR was higher in rheumatic MS rather than non-rheumatic MS
(p=0.02). There was no relationship between type of mitral stenosis
(rheumatic or non-rheumatic) and early mortality after mitral valve
replacement (p=0.8).
Conclusion: Our findings may show type of mitral stenosis (rheumatic or
non-rheumatic MS) affect on postoperative outcomes especially incidence
of atrial fibrillation and some complications after mitral valve replacement.

24.
Successful Induced Hypothermia Post-Cardiac Arrest:
Evaluating Protocols to Expand Therapeutic Scope
M CHAN, C HOFFMAN, W HUI, DJ KUTSOGIANNIS, P TOPIPAT,
R WILLIAMS
University of Alberta, Canada
Objectives: Induced hypothermia (IH) improves outcomes, using stringent
selection criteria. Systematic reviews demonstrating positive outcomes only
included studies where cooling was initiated within 6 hours of arrest.
Primarily, we evaluated our IH protocol in terms of survival and neurological
outcome, comparing IH patients to matched controls. Our secondary
objective was to gain insights about benefits of IH in relation to described
selection criteria and protocols.
Methods: Records from consecutive cardiac arrest patients admitted to our
cardiac/intensive care unit were reviewed and classified into groups IH and
Control. IH was considered for patients resuscitated approximately 5-10
min after arrest, and were neurologically unresponsive Glasgow Coma Scale
(GCS) 3-6, after return of spontaneous circulation (ROSC). 32-33oC cooling
protocol was achieved for 24 hours: iv 30 ml/kg iced saline, room temperature
15oC, ventilator temperature 31oC, cooling blanket, ice packs around head,
axillae, and groins, room fans, neuromuscular blockade, sedation, analgesia.
Patients within the IH group were then stratified into groups, including:
out-of-hospital vs in-hospital arrest; witnessed vs non-witnessed arrest; initial
rhythm of VF/VT or other, and time to initiate cooling (<6 vs >6 hr).
Results: 269 patients were admitted, with 249 charts available for review
(IH group n=59; Control n=190). The IH group was more neurologically
unresponsive at admission, arrested out-of-hospital more often, and had
longer times to ROSC. Controls with GCS ≤6 (n=105) died more often than

B12

IH patients (76.2% vs 59.3%; p=0.037), yet had similar times to ROSC.
Neurological outcome was poorer for the IH group, but similar after adjusting
for GCS. Only 27.3% of IH patients who arrested in-hospital died, and only
51.1% died when cooling was initiated within 6 hours.
IH patients with in-hospital arrest died (27.3%) significantly less often than
those IH patients arresting out-of-hospital (66.6%) and those without IH
(76.2% in controls with GCS ≤6). IH patients with initial rhythms other
than VF also seemed to derive benefit (65.2% vs 76.2% death in controls
with GCS ≤6), while those with non-witnessed arrests had similar survival
(76.9% deaths) to the controls with similar GCS.
Conclusion: IH provided survival benefit when considering patients of
similar neurological status on admission. IH may benefit patients who do
not meet currently recommended selection criteria.
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Effect of Milrinone on Short Term Outcome of Patients with
Myocardial Dysfunction Undergoing Off-pump Coronary Artery
Bypass Graft: A Randomized Clinical Trial
M HADADZADEH, SH HOSSEINI, SMY MOSTAFAVI POUR MANSHADI,
N NADERI, M EMAMI MEYBODI
Shahid Sadoughi University of Medical Science and Ali ben Abitaleb Medical
College (Islamic Azad University), Iran
Background and Objectives: Myocardial dysfunction is a major
complication in cardiac surgery that it needs inotropic support. This study
evaluates the effect of milrinone on patients with low ventricular ejection
fraction undergoing off pump coronary artery bypass graft (OPCAB). The
present study was designed to evaluate effect of milrinone administrated on
myocardial dysfunction.
Materials and Methods: Eighty patients with Low ventricular ejection
fraction (<35%), candidate for elective OP CAB, were enrolled at this study.
They were randomly assigned to two groups. One group received milrione
(50 µg/kg) intravenously and another group received a saline as placebo
followed by 24 hours infusion of each agent (0.5 µg/kg/min). Short outcome
of patients such as hemodynamic parameters and left ventricular ejection
fraction were variables evaluated.
Results: Serum levels of creatine phosphokinaze, the MB isoenzyme of
creatine kinaze, occurrence of arrhythmias and mean duration of mechanical
ventilation were significantly lower in milrinone group (P<0.05). The mean
post operative left ventricular ejection fraction was significantly higher in
milrinone group (P=0.031). There were no statistically significant differences

between two groups about intra-aortic balloon pump, inotropic support
requirement, myocardial ischemia, myocardial infarction, duration of
inotropic support, duration of intensive care unit stay, mortality and morbidity
rate.
Conclusion: Administration of milrinone in patients undergoing off pump
coronary artery bypass graft with low ventricular ejection fraction, is useful
and effective.

.

26.
The Effects of Synergy Model on Nurses' Quality Care and the
Satisfaction of Patients with ACS
KJ MAHDI
Jahrom-Jahrom Medical Science University, Jahrom, Iran

Conclusions: Applying Synergy Model as a basis for receiving nursing cares
was effective in increasing patient satisfaction and in the performance of
nurses of cardiac intensive care units (improve outcome).

Background: Despite many progresses in the improvement of care status and
the management of acute coronary syndrome, cares quality is far from the
desirable conditions. Today, due to the great emphasis on resources
management, costs control, the effectiveness of patient care, improving quality
and responsibility, the good patient care is necessary. Two dimensions are
referred for improving the quality: process (standard-based and safe services)
and resultant (client satisfaction). The present study, aimed at determining
the impact of Synergy Model on nurses' performance and the satisfaction of
the patients with acute coronary syndrome.
Methods: In a quasi-experimental study in a two-group and two-step form, a
sample of 22 nurses and 64 patients with acute coronary syndrome in cardiac
intensive care units of some university hospitals in 2010-2011 were recruited.
Synergy Model was explained and carried out for the studied groups in a
workshop and its impact on nurses performance in different areas and patients'
satisfaction was examined by using two checklists: "examining the nurses'
performance quality" and "examining the patients' satisfaction".
Results: Differences between the mean scores of the nurses in communicative,
supportive, care and educational domains and total performance were
statistically significant before and after the intervention (p<0.001). However,
in therapeutic domain, changes were not significant. There was a statistically
significant difference between the average satisfaction score of the two groups
(p<0.001).
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Fatty Liver and Blood Pressure Response During Exercise
AG LAURINAVICIUS,1 F NARY,1 M BLAHA,2 K NASIR,2 R CONCEICAO,1
JA CARVALHO,1 R BLUMENTHAL,2 R SANTOS1
1
Preventive Medicine Center Albert Einstein Hospital, Brazil; 2Johns Hopkins
School of Medicine, Baltimore, USA
Background: Fatty liver (FL) is associated with insulin resistance, the
metabolic syndrome, subclinical inflammation and a higher risk of
cardiovascular disease. Blood pressure hyperreactivity during peak exercise
is associated with an increased risk of developing hypertension and with
increased cardiovascular risk. Clinical predictors of hyperreactive response
(HRR) are not well established. We studied the association between fatty
liver and HRR.
Methods: We evaluated 7995 consecutive non-hypertensive individuals
(mean age: 41.7 years, 24.9% female) who underwent symptom limited
exercise stress test, abdominal ultrasonography and extensive clinical and
laboratory evaluation as part of a check-up protocol between 2006 and 2009.
FL was detected by abdominal ultrasonography. HRR was defined by a
systolic blood pressure higher than 220 mmHg and/or elevation of 15 mmHg
or more in diastolic blood pressure. The association between FL and HRR
was tested by multiple logistic regression.
Results: The prevalence of FL was 28.4% (n=2270). Overall, 7% (n=559) of
the study population presented HRR. Subjects with FL showed a higher
prevalence of HRR than those without FL (12.7% vs. 4.7%, OR 2.14, 95%
CI 1.78 to 2.56, p<0.001). Other variables associated with HRR were: Body
Mass Index (BMI)>25 kg/m2 (OR 2.49, 95% CI 2.01 to 3.08, p<0.001); fasting

glucose >100 mg/dL (OR 1.69, CI 95% 1.34 to 2.14, p<0.001); C-reactive
protein >2 mg/L (OR 1.40, 95% CI 1.15 to 1.70, p=0.001); and low HDLcholesterol levels (OR 1.22, 95% CI 1.02 to 1.46, p=0.034). After adjustment
for these variables as well as baseline blood pressure, only FL (OR 1.37, 95%
CI 1.12 to 1.67, p=0.002 ) and BMI> 25 kg/m2 (OR 1.41 95% CI 1.12 to
1.67, p=0.002 ) remained statistically significant predictors of HRR.
Conclusions: FL is an independent predictor of HRR. This association may
partially explain the increased cardiovascular risk observed in FL.

28.
Blood Pressure Hyper-Reactivity during Exercise is related to
the Degree of Hepatic Steatosis
AG LAURINAVICIUS, F NARY, R CONCEICAO, JA CARVALHO,
R SANTOS
Preventive Medicine Center Albert Einstein Hospital, Brazil
Objectives: Recently, hepatic steatosis (HS) has been identified as a major
independent predictor of blood pressure hyper-reactivity on the exercise
test. However, whether this association is homogeneous or if it varies
depending on the degree of HS is still to bee defined. The purpose of this
study was to stratify the incidence of blood pressure hyper-reactivity by the
degree of HS evaluated by abdominal ultrasonography.
Methods: We evaluated 11,941 consecutive asymptomatic subjects who
underwent exercise stress test, abdominal ultrasonography and extensive
clinical and laboratory evaluation between 2010 and 2011. Those without
HS (N=7.795) and those with not adequately quantified HS (N=2.541) were
excluded. HS was classified into three degrees (mild, moderate and severe)
in accordance with conventional ultrasound parameters. Blood pressure
hyper-reactivity was defined by a systolic blood pressure higher than 220
mmHg and / or elevation of 15 mmHg or more in diastolic blood pressure.
The association between HS degree and blood pressure hyper-reactivity was
tested by multiple logistic regression.
Results: HS prevalence was 34,7% (N=4.146). HS was adequately quantified
in 1.605 (average age: 42 years, 6.8% female): 1.120 (69.8%) were classified
as mild steatosis; 296 (18.4%) as moderate steatosis; and 189 (11.8%) as
severe steatosis. Overall incidence of blood pressure hyper-reactivity in
individuals with HS was 7.2%. When evaluated according to the degree of
HS, incidence of blood pressure hyper-reactivity was 5.6% (N = 63) in mild
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steatosis subjects; 7.1% (N=21) in moderate steatosis subjects; and 16.9%
(N=32) in severe steatosis subjects. The association between blood pressure
hyper-reactivity and the degree of HS was statistically significant (p<0.001).
Final multivariate model showed severe steatosis as the strongest independent
predictor of blood pressure hyper-reactivity (OR 2.4, CI 1.44 to 3.98,
p<0.001).
Conclusions: Blood pressure hyper-reactivity during exercise is related to
the degree of HS. Despite the known ultrasound limitations in HS assessment,
routine HS quantification can bring relevant information about individual
cardiovascular risk.
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Relationship of Serum High Sensitivity C-reactive protein to
Metabolic Syndrome-Bulgarian Prospective Study
G NAYDENOVA, 1 A ATANASOVA, 2 RTZVEOVA, 3 M BORISOVA, 4
NS BASHA5
1
Cardiology Department, Medical University, Pleven; 2Medical University,
Pleven; 3Center of Molecular Medicine, Sofia; 4Private Heart Hospital,
Pleven, Bulgaria; 5Cardiologist in Trainee, India
Obectives: High levels of hs-CRP in the context of the presence of the The
Mets justify a significantly higher risk of cardiovascular events and predict
with great accuracy the onset of insulin resistance. In clinical practice we
can use the hs-CRP concentrations as a like certainly mark for determine
cardiovascular complications.
Methods: Subjects were 500 Bulgarian clinical healthy participants from
Pleven region (201 males and 299 females). A subset of individuals with
Mets was selected. Anthropometric and hematologic indexes were defined.
Have been used: statistical test of Mann-Witney test and Kruskall-Wallis
test for quantitative variables with nonparametric distribution, correlation
and regression analysis.
Results: The metabolic syndrome frequency among the study population
was as follows: age of 35 years are found in 13% of women and 18% men,
36 to 45 years old − 19% of women and 45% men and 46 years old − in 40%
of women and 30% men. An ANOVA statistical analysis to determine the
differences in hs-CRP in subjects with and without the metabolis syndrome.
The moderate increase of hs-CRP concentration among men is related with
2.41- fold increase of the risk for metabolic syndrome (OR=2.41, 95% CI:

1.36-4.33). The moderate increased of hs-CRP concentration among women
is associated with 5.03- fold increase of risk for metabolic syndrome (OR=
5.03, 95% CI: 2.23-11.13).
Conclusion: The aim of our study was to clarify the existence of a link
between the level of hs-CRP and components of the Mets. We found that
serum levels of hs-CRP were positively associated with obesity in men
without Mets. There is a positive and significant relationship of obesity to
the levels of hs-CRP in women with and without Mets. In men with a modest
Mets Rights correlation (r=0,31÷0,5) between hs-CRP and waist
circumference, BMI, LDL-cholesterol, blood glucose, and LDL / HDL. In
women with moderate Mets notes straight correlation (r=0,28÷0,52) between
hs-CRP and body weight, waist circumference and BMI.The risk of metabolic
syndrome increases with the level of hs-CRP, and this relationship is more
pronounced in women.

30.
Obesity in Egyptian Children: Effect on Cardiac Function and
Dimensions
IA SAAD,1 TS IBRAHIM2
Pediatrics Department, Faculty of Medicine, Cairo University; 2Child Health
Department, National Research Center, Egypt

1

Background: Obesity is an increasingly common condition in industrialized
and developing countries, affecting both adults and children and increasing
the social burden due to incident cardiovascular disease. Numerous studies
suggested that obesity and increased Body Mass Index are risk factors for
left ventricular hypertrophy which is proved to be independent risk factor
for cardiovascular morbidity and mortality.
Objectives: This study proposed to define the effect of obesity in Egyptian
children on cardiac function and dimensions also to investigate the possible
relation between obesity and other co-morbid cardiovascular risk factors.
Methods: The current study is a prospective descriptive study conducted
from January 2009 to March 2010 and included 44 children with exogenous
(simple) obesity aged from 4 to 16 years with a mean of 8.54±2.4 years in
addition to a healthy normal weight, matched age and sex 35 children as a
control group. All study groups underwent clinical examination, lipid profile
in addition to meticulous echocardiography study with special concern to
measurement of wall thickness, mass, mass index, Ejection fraction,
Fractional shortening, isovolumetric relaxation time, E/A and myocardial
performance index.
Results: Our results revealed that blood pressure was comparable in both
groups and mean serum triglyceride level (though in the normal level) was
significantly higher in the obese group with P =0.035. Also left ventricular
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wall thickness, mass and mass index were significantly higher in obese group
compared to normal weight group with P value 0.001, 0.045 & 0.035
respectively. Myocardial systolic function was comparable in both groups
but diastolic function presented by isovolumetric relaxation time and E/A
was significantly different in favor for the control group. We also observed
a significant positive linear relationship between body mass index and both
left ventricular thickness and left ventricular mass. However by correlating
cardiac dimension with the lipid profile no significant relation could be
elicited.
Conclusions: Our data showed that obesity in the absence of dyslipidemia
and hypertension (as co-morbid cardiovascular risk factors) is associated
with increased left ventricular wall thickness and mass also it is a risk factor
for left ventricle diastolic dysfunction
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Sampurna Hriday Shudhikaran (SHS): A Novel Noninvasive
Herbal Procedure to Improve Effort Tolerance in Chronic Heart
Failure
R SANE, M HANCHATE
Madhavbaug Ayurvedic Cardiac Rehabilitation Center, Raigad, India
Objective: Heart disease is a worldwide problem affecting people in all
communities. India will bear 60% of the world's heart disease burden in the
next two years and the average age of patients with heart disease is lower
among Indian people who belong to the economically productive group. It
is not only the lack of resources but also the inability to continue with the
costly treatment that further adds to the woes of the patients. Inadequate
pumping of heart leads to chronic heart failure which causes effort
intolerance. Conditions like coronary artery disease, hypertension, post
myocardial infarction, Cardiomyopathy, heart valve disease ultimately leads
to CHF. Present study was carried out to evaluate the effect of the Sampurna
Hriday Shuddhikaran (SHS) model in improving the exercise tolerance
capacity of chronic heart failure patients.
Methods: Novel noninvasive interventional health model Sampurna Hriday
Shuddhikaran (SHS) procedure was used to treat CHF patients at
Madhavbaug Cardiac Rehabilitation Centre, Mumbai (INDIA). SHS
combines the 4 pronged interventions of Snehan (oil massage to reduce
vascular tone), Swedan & Hrid Dhara (thermal therapy to reduce salt &
water retention and causing vasodilatation) and Basti (rectal herb to increase
cardiac contractility) was used in each patient who received twice daily
sessions of 90 mins each for 6 consecutive days. Symptomatic patients (age
17-80 years) with CHF (Grade 1-3 of NYHA classification), of either gender,
with ejection fraction more than 25% & provided written informed consent
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were included in study. Patients with history of Myocardial infarction in
last 2 weeks, uncontrollable hypertension (SBP ≥180 & DBP ≥110 mmHg),
severe hepatic/renal insufficiency, pregnancy/lactating were excluded.
Evaluation parameters used were − Exercise Tolerance capacity [as measured
by standard 6 minute walk test (6MWT); Improvement in Stress test (ST)];
Improvement in Grade of Symptoms (GOS); Improvement in maximum
oxygen uptake (VO2max) & Improvement in metabolic equivalents (METs),
which were taken on day 1 (pre-intervention) and on day 7 (postintervention).
Results: A total of 1200 patients were evaluated. Mean age=55±9 years; Mean
BMI=24.5±3.4 kg/msq; Preexisting Diabetes Mellitus on treatment=40%;
Past history of coronary angiography/bypass=7%. The mean improvement in
exercise tolerance as measured by in 6MWT & ST post- intervention was
70.6 meters/6 mins & 132.1±85.4 seconds/9 mins (p=0.03) respectively. The
corresponding improvement in VO2max & METs was 3.1±3.44 lt/min &
2.23±1.9. Patient symptoms also improved. Vital parameters were stable. No
significant adverse events were seen in any patient.
Conclusions: Novel noninvasive Sampurna Hriday Shudhikaran procedure
was effective in improving the exercise tolerance & oxygen uptake in
symptomatic chronic heart failure patients and this improvement was
independent of age, gender and BMI.
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Associations between Muscle Fitness in Extremity and Trunk with
Metabolic Syndrome
YC CHIU, MW TSAI
National Yang-Ming University, Taiwan
Objectives: We studied the associations of muscular fitness in extremity
and trunk with metabolic syndrome (MS) in adult men and women, because
such data are limited and demanded in management of MS.
Methods: We studied a population sample of 1743 men and 834 women
aged 20-77 years, having not any medical history of chronic diseases and
musculoskeletal problems, from the 2001-2006 database of a health
examination center. Muscular fitness included hand and leg dynamometers
for maximal grip force and functional leg strength, one-minute curl up test
for abdominal muscle endurance. Possible confounding variables, such as
age, sex, and weight were also extracted for adjustment. Based on the criteria
of MS, subjects with a cluster of three or more metabolic abnormalies were
classified as having the MS.
Results: Both male and female adults with MS (n=561) had significantly
weaker extremity muscle fitness (grip, leg force) and abdominal muscle
endurance than subjects without MS (n=2016) after age and weight
adjustment. The ratio of abdominal endurance to grip force was also
significantly lower among adult men with MS. Men in the poor rank of
grip, leg force and abdominal endurance had 1.51-, 1.44- and 1.37-fold higher
risks (p<0.05) of MS than those in the good and excellent rank of each
muscular fitness after adjustment. But such associations in adult women
with the similar level of risks were not significantly.

Conclusion: Low muscular fitness in both extremity and abdominal muscles
is associated with metabolic syndrome in adult men and women. Furthermore,
a lower ratio of abdominal endurance to grip force in adult men with
metabolic syndrome suggests the decrease in abdominal muscle fitness being
dominant in reflecting risk of metabolic syndrome.
The grant is supported by Incubated project of National Yang Ming University
(96A-D-D128) and partly from the National Science Council (NSC-99-2627B-002-018).

2.
Impact of Cardiac Rehabilitation Nurse in a Multi-Disciplinary
Cardiology Clinic on Patient Recruitment
DBL TAN, YMW CHOW, CSC SOH, S TONY, CP WONG, JKK LOH,
HH HO, PPJ ONG, D FOO
Cardiac Rehabilitation Centre & Department of Cardiology, Tan Tock Seng
Hospital, Singapore
Objectives: Cardiac Rehabilitation Program (CRP) is a multi-disciplinary
program that has been shown to lower patients' risk of future cardiovascular
events and mortality. It improves functional capacity, psychological wellbeing, quality of life and cardiac risk factors (lipid profiles and obesity
indices). Patients are usually introduced to CRP during hospitalization for
an acute cardiac event or after undergoing coronary revascularisation.
Although the benefits of CRP are plentiful, the rate of participation is
generally low. It is unclear whether introduction of CRP to patients in
different clinical settings (in-hospital versus outpatient) would influence
their decision to participate. We examined whether involving CRP nurse as
the first point of contact post discharge in a multi-disciplinary cardiology
clinic would have an impact on patient recruitment for CRP.
Methods: From January 2011 to May 2012, 932 eligible patients who had
received percutaneous coronary intervention (PCI) at our institution were
introduced to CRP. For the first group (Group A), 546 patients were
introduced to CRP during hospitalization. Patients were given the necessary
education/counseling and were given the option of attending CRP before
discharge. For the second group (Group B), 386 patients were introduced to
CRP in a newly formed, multi-disciplinary cardiology clinic (since October
2011) with the CRP nurse being the first point of contact. Patients were seen
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2 weeks after discharge from hospital. For both groups, CRP appointment
was arranged immediately after patient had consented.
Results: Study groups did not differ significantly at baseline. For Group A,
290 (53.1%) patients agreed to participate in CRP versus 311 (80.6%) patients
in Group B (p<0.001). In addition, 217 (74.8%) patients from Group A
showed up for their CRP appointment versus 274 ( 88.1%) patients in Group
B (p< 0.001).
Conclusion: The involvement of CRP nurse in a multi-disciplinary
cardiology clinic has a significant impact on patient recruitment as
demonstrated by a higher sign-up and show-up rate for CRP. Early
introduction of CRP to patients in the outpatient setting after hospital
discharge could be considered as an alternative method to boost patient
participation in CRP.
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Adherence to Cardiac Risk Factor Modification Behaviors and
Problem Solving Skills in Cardiac Rehabilitation Patients
S RADI,1 SM MOORE2
King Saud Bin Abdulaziz University for Health Sciences, College of
Nursing, National Guard Health Affairs, Jeddah, Saudi Arabia; 2Case Western
Reserve University, Cleveland, OH, USA

1

These findings suggest that interventions to increase patient problem solving
skills may be helpful to improve cardiac patients' adherence to diet and
stress management. The finding that problem solving was not related to
adherence to medical regimen may be because adherence to a medical
regimen is influenced by several factors unrelated to problem solving, such
as severity of side effects or number of medications.

Problem solving skills have been shown to be an important component of
the behavior change process. Guided by the Social Problem Solving Model
of Ewart (1989), the purpose of this study was to determine the relationship
between problem solving skills and adherence to cardiac risk factor
modification behaviors of diet regimen, medication regimen and stress
management in cardiac rehabilitation patients. Measures of problem solving
and adherence behaviors were taken in a convenience sample of 99 Phase II
cardiac rehabilitation patients (66 males and 33 females) with myocardial
infarction, coronary artery bypass or angioplasty who ranged in age from
38 to 85 years (M=63, SD=11.5). Problem solving skills were measured
using the Problem Solving Inventory (Heppner 1988). Adherence to cardiac
risk factor modification behaviors was measured using the Health Behavior
Scale (Miller Wikoff, McMahon, Garrett, & Gohnson, 1982, 1990). Data
were collected in face-to-face interviews during the 6th week of cardiac
rehabilitation. Results showed significant relationships between problem
solving skills and adherence to prescribed diet (r=-0.296, p=0.003) and stress
management (r=-0.254, p=0.011). No significant relationships were found
between problem solving skills and adherence to medication regimen. No
difference in problem solving skills or adherence behaviors were found
between men and women and neither problem solving skills nor adherence
behaviors varied by age or co-morbidity (measured by Charlson Scale, 1987).

4.
Validation of Incentive Spirometry for the Lung Function
Recovery of Post-Cardiac Surgery Patients
HY TSAI, LY KUO, BY CHEN, MW TSAI, HY HUANG, JC CHEN, CL
HSU, YS LIN, WN CHEN, FH CHENG, CY CHEN
Cardiac Rehabilitation Center, Cheng Hsin General Hospital, Taipei, Taiwan
Objectives: The aims of this study were using the incentive spirometry (IS)
to predict the recovery of lung function and to evaluate its responsiveness
as a tool in assessing lung function in patients underwent cardiac surgery.
Methods: This was a prospective cohort study. A total of 112 subjects (25%
female, aged 62.4±10.8 years old) underwent cardiac surgery were recruited.
Spirometry and IS were used to assess the lung function at admission
(preoperatively) and at discharge (postoperatively). To test criterion validity,
we used Pearson's correlation coefficient to analyse the correlation between
volume readings of IS and forced vital capacity (FVC). Patients whose %pred
FVC improved from admission were categorized as lung function recovery
group (n=31), otherwise as non-recovery group (n=81). To test the
responsiveness of IS, we compared the ratio of ISdischarge / IS preop volume
readings between recovery and non-recovey groups. Receiver operating
characteristic (ROC) curve analysis was also used to identify the optimal
cut-off point of ISdischarge / ISpreop ratio in predicting the recovery of lung
function.
Results: Our results showed that the volume of IS at admission and discharge
were 1932.6±600.7 mL and 1789.3±573.8 mL (p<0.05). And, IS performance
significantly correlated to FVC at both admission and discharge (r=0.71
and 0.76. p<0.001). The ratio of ISdischarge / ISpreop was significantly
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different between recovery (101.3±20.5) and non-recovey (91.5±21.3) groups
(p<0.05). The optimal cut-off point of IS ratio was 93%, with sensitivity of
62% and specificity of 68% (AUC =0.65 (95% CI: 0.53 to 0.76).
Conclusions: There was a high correlation between lung volume measures
with spirometry and incentive spirometry for patients underwent cardiac
surgery. The postoperative relative to the preoperative IS volume could
respond the patients with poor lung function recovery after cardiac surgery.
Our findings suggest that the incentive spirometry can be used not only as a
breathing training tool but also as a valid and low-cost tool to assess lung
function in the bedside care.
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The Effects of Core Muscle Exercise and Aerobic Exercise Training
on Respiratory Efficiency in Patients Underwent Cardiac Surgery
JC CHEN,1 CL HSU,1 FH CHENG,1 MW TSAI,2 HY HUANG,1 LY KUO,1
CY CHEN,1 BY CHEN,1 YS LIN,1 HY TSAI,1 WN CHEN1
1
Cardiac Rehabilitation Center, Cheng Hsin General Hospital; 2Department
of Physical Therapy and Assistive Technology, National Yang Ming
University, Taipei, Taiwan

(from 35.95±7.46 to 27.6±4.71, p<0.00) in exercise group after 3 months,
but not in control group (PIF from 3.00±2.11 to 3.57±1.45 L/min, and VE/
VCO2 slope from 31.05±5.46 to 28.33±4.11).
Conclusions: A core muscle exercise and aerobic exercise training improve
the respiratory efficiency on patients underwent cardiac surgery. Our findings
suggest that combined core muscle exercise and aerobic exercise training
can have great effects at the clinical implication.

Objective: To examine the effect of core muscle exercise and aerobic exercise
on respiratory efficiency in patients underwent cardiac surgery.
Methods: 37 patients who underwent cardiac surgery in a heart center of
general hospital were inrolled during 2011. They were classified to exercise
group (n=23, 30% female and 63.77±11.58 years) and control group
(n= 14, 29% female and 61.73±10.77 years). Patients in the exercise group
participated a 30 to 40-minute aerobic training and a 50-minute core muscle
training mat exercise which was based on Pilates elements for 3 months.
The control group were received uaual medical care. Outcomes measured
including of forced vital capacity (FVC), forced expiatory volume in one
second (FEV1), peak inspiration flow (PIF), peak expiration flow (PEF),
and respiratroy efficiency of the minute ventilation-carbon dioxide
production relationship (VE/VCO2 slope) from pulmonary function test and
cardiopulmonary exercise test at the baseline and after 3 months intervention.
Independent-T test, chi-square test, and paired-T test were used to examine
the effect of the intervention.
Results: Both exercise and control group had significant improvements of
FVC and FEV1 (p<0.05) after 3 months. There were significant improvements
of PIF (from 2.49±1.31 to 3.25±1.65 L/min, p=0.007) and VE/VCO2 slope

6.
An Evaluation on a Structured Health Qi-Gong (Baduanjin)
Program for Patients with Cardiac Diseases in Cardiac
Rehabilitation Program
KY FUNG, TM LEE, YB SO
Occupational Therapy Department, Tung Wah Eastern Hospital, Hong Kong
Objectives: Health Qi-Gong is a culturally relevant health maintenance
activity to Chinese people. Numerous studies found that it has positive
influence towards health conditions. Recently, the practice of Health QiGong is used by occupational therapists as a complementary program in
different chronic diseases management, including cardiac diseases. Patients
with cardiac diseases face not only physical problems but often also suffering
from long term psychological turmoil. Occupational therapist in the Cardiac
Rehabilitation and Resource Centre (CRRC) of Tung Wah Eastern Hospital
had started using Health Qi-Gong − Baduanjin (
) since July 2010 in
Phase II Cardiac Rehabilitation Program to enhance the service quality. This
study aimed to examine whether the practice of Baduanjin could promote
the physical and psychological functions of patients with cardiac diseases.
Methods: Through purposive sampling, a total of 19 cardiac patients (mean
age 63.9) with blood pressure problem and/or psychological problems were
enrolled into the HQG classes and assigned into group A or B. Patients in
group A (n=11) would attend 4 weekly 75 minutes sessions in CRRC to
learn the Baduanjin. Patients in group B (n=8) would have additional 8
weekly practice sessions with each duration 30 minutes in the center after
the 4 weekly sessions learning the Baduanjin. Both groups were encouraged
to practice at home daily from 0 week to 12th week. Individual lifestyle
counseling would be offered to both groups of patients who had difficulty
to integrate the practice of HQG in daily life. Assessments on physical
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parameters including systolic and diastolic blood pressure; and heart rate
were conducted at baseline, 4th week and 12th week, while the psychological
parameters using Hospital Anxiety and Depression Scale and the generic
quality of life measure using WHO-5 were assessed at baseline and 12th
week.
Results: All 19 patients in either group A or B had positive changes in the
mean difference of all physical and psychological parameters after attending
the HQG class. The results did not show significant differences in any
parameters between group A and B despite more weekly practice sessions
were provided in group B. However, when data of patients with good and
poor compliance to daily life practice were extracted and grouped together
for analysis, statistical significant improvement were found in those patients
with good compliance in systolic blood pressure (p=0.01), anxiety (p=0.04)
and depression (p=0.01). In addition, all patients with good compliance to
daily practice showed normalized systolic blood pressure after practicing
Baduanjin. This HQG program also received positive and encouraging
feedbacks from patients and most of them agreed that Baduanjin could help
to enhance their general health.
Conclusion: The study showed that the Baduanjin is well accepted and
suitable for patients with cardiac diseases. It also pointed out that compliance
to daily life practice was one of the key success factors to achieve a better
health. Thus, through developing a habit to practice Health Qi-Gong
regularly, it could be beneficial in improving both physical and psychological
functions as well as the quality of life of patients.
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Psychological Outcome of Cardiac Rehabilitation Programme
Among D.A.S.S. Positive Patients Enrolled in Hospital Serdang
MY SAARI, 1 A ATIKAH,1 I ZURIANTI,1 J ROHANA, 1 NA HARRIS, 2
KZ ATHIRAH,2 N ASIYAH,2 AN NURUL,2 A SAKINAH2
1
Medical Rehabilitation Department, Hospital Serdang; 2Medical Faculty,
International Islamic University of Malaysia, Malaysia
Objective: To measure psychological outcome of cardiac rehabilitation
programme among D.A.S.S. (Depression Anxiety Stress Scalespositive)
enrolled in Hospital Serdang.
Method: A retrospective cohort study design, whereby a collection data
was obtained from recorded notes of the participants of cardiac rehabilitation
who had completed phase 3 medical surveillance.
Result: Fifteen (20.83%) out of 72 participants were psychologically distress
based on DASS at initial evaluation of CRP and upon completion there is
60% significant overall improvement noted (Z=-2.196, P=0.013). Further
analysis also done on individual components of DASS (i.e. depression,
anxiety and stress) and we found that only anxiety modelled a statistical
significant improvement of severity after completion of CRP (Z=-2.127,
P=0.033). However, individual phases of CRP failed to give an impact
independently (P>0.05).
Conclusion: This study has shown that CRP did have an impact on
psychological status of participants if complete adherence and compliance
is meeting. Hence, the findings of this research should be used to further
emphasize the need of clinical preventive medicines such as CRP integrated
in the treatment equation of cardiac patients.

8.
Difference of Blood Pressure Response during Exercise in Normal
Subjects and Patients with Myocardial Infarction
W CHOU,1,3 CJ SU,1 CL CHEN,4 CN YEH,1 KS YUAN,5 JT LIU2
Department of Physical Medicine and Rehabilitation, Chi Mei Medical
Center, Tainan; 2Department of Physical Medicine and Rehabilitation, Chi
Mei Hospital, Liuying, Tainan; 3Department of Recreation and Health-Care
Management & Institute of Recreation Industry Management, Chia Nan
University of Pharmacy & Science, Tainan; 4Department of Physical Therapy,
I-Shou University, Kaohsiung; 5Department of Business Management,
National Sun Yat-sen University, Kaohsiung, Taiwan

1

Results: 43 post-MI patients and 35 college students with no systemic disease
were
involved in this study. The results of the regression model showed that
.
VO2R is predictive of SBPR in both groups (MI group: F=211.097, p<0.001;
B=0.802, p<0.001; R-squared=0.667, p<0.001, Normal group: F=2491.941,
p<0.001; B=0.967, p<0.001; R-squared=0.827, p<0.001). Also, the Beta value
in each drug groups are all lower than the normal group (ACEI: 0.771, Alpha
Blocker: 0.759, Beta Blocker: 0.81, CCB: 0.739, Diuretics: 0.762, None:
0.851).
Conclusion:
From the slope of the linear regression line between SBPR and
.
VO2R, SBP respond more slowly in post-MI group when compared with the
normal population, with or without hypertension drugs use.

Objectives: Exercise prescription for people with cardiovascular disease has
been well established for years. Whereas, there is few literature discuss about
the systolic blood pressure response during maximal graded exercise tests
(GXTs) in patients after myocardial infarction (MI) event. By performing
maximal GXTs, our study investigated the difference of SBP response between
normal subjects and post-MI patients.
Methods: We retrospectively review patients with MI who went through
maximal GXTs in our medical center from 2009 July to 2011 January. Normal
.
subjects were
students randomly chosen from university. Same as the VO2
.
reserve (VO2R) method, we then distribute the SBP recorded during maximal
GXTs into percentile rank as maximal SBP becomes 100% and resting SBP
as 0% (SBP reserve method, as SBPR). .A regression model were established
with SBPR as a dependent variable and VO2R as an independent variable. We
also divide the patient into smaller groups by hypertension drugs they use
(angiotensin-converting-enzyme inhibitor (ACEI), Alpha Blocker, Beta
blocker, Calcium Channel blocker (CCB), Diuretic, None) and further analyze
to see if drugs might affect SBP respond during exercise.
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Systolic Blood Pressure Reserve in Exercise Intensity Prescription
of Post-Myocardial-Infarction Patients with Arrhythmia
CJ SU,1 W CHOU,1,3 CL CHEN,4 CH CHEN,1 KS YUAN,5 YM LO2
1
Department of Physical Medicine and Rehabilitation, Chi Mei Medical Center,
Tainan; 2Department of Physical Medicine and Rehabilitation, Chi Mei
Hospital, Liuying, Tainan; 3Department of Recreation and Health-Care
Management & Institute of Recreation Industry Management, Chia Nan
University of Pharmacy & Science, Tainan; 4Department of Physical Therapy,
I-Shou University, Kaohsiung; 5Department of Business Management, National
Sun Yat-sen University, Kaohsiung, Taiwan
.
.
Objectives: VO2 reserve (VO2R) method reflect the rate of energy
expenditure during physical activity more accurately than the other exercise
intensity prescription methods. For practical reason, Heart rate reserve (HRR)
and rate of perceived exertion (RPE) are the most common used method for
quantification of exercise intensity. However, in patients with arrhythmia,
there is no feasibly quantified method as HRR can be used. Our study is to
investigate whether systolic blood pressure reserve (SBPR) method can be
used in arrhythmic patients when prescribing exercise intensity.
Materials and Methods: We retrospectively review patients who went
through maximal graded exercise testing in our medical center from 2009
July to 2011 January. Twenty-seven patients with arrhythmia
. were selected.
SBP during
the exercise is recorded with the corresponding VO2 value. Same
.
as the VO2 reserve method, we then distribute the SBP into percentile rank,
as maximal SBP becomes 100% and resting SBP as 0%. A regression
model
.
were established with SBPR as a dependent variable and VO2R as an
independent variable.

Results: The study population consisted of 27 post-myocardial-infarction
(post-MI), arrhythmic patients with mean age of 55.67±13.35 years; height:
166.74±7.41 cm and weight: 70.24±16.18 kg. Of the treatment they received
after MI event, 5 of them had percutaneous transluminal coronary
angioplasty, 7 had coronary artery bypass graft, 10 had valve repair, and
1 have. aortic aneurysm repair. The results of the regression model showed
that VO2R is predictive
of SBPR (F=117.792, p<0.001; B=0.7656,
.
p<0.001). Besides, VO2R was found to account for 61% of variance in SBPR
(r2 =0.614, p<0.001).
Conclusions: When prescribing exercise intensity
in post-MI patients with
.
arrhythmia, SBPR has good correlation with VO2R and can serve as a better
quantification method in practical use.

10.
Patient Dignity and Its Related Factors in Heart Failure Patients
H BAGHERI,1 F YAGHMAIE,1 T ASHKTORAB T,1 F ZAYERI2
1
Faculty of Nursing and Midwifery, Shahid Beheshti University of Medical
Sciences; 2Faculty of Paramedical Sciences, Shahid Beheshti University of
Medical Sciences, Tehran, Iran
Introduction: Maintenance and promotion of patient dignity is an ethical
responsibility of health care workers. The aim of this study was to investigate
the patient dignity and related factors in heart failure patients.
Materials: In this qualitative study, 22 patients with heart failure were chosen
by purposive sampling and Semi-structured interviews were conducted until
data saturation.
Results: Factors related to patient dignity were divided into two main
categories: patient/care index and resources. Intrapersonal features (inherent
characteristics and individual beliefs) and interpersonal interactions
(communication, respect, enough information, privacy and authority) were
classified as components of the patient/care index category. Human resources
(management and staff) and environmental resources (facilities and physical
space) were classified as components of resources category.
Conclusion: The results will increase the understanding of healthcare staff
regarding patient dignity and its relevant factors, and provide information
regarding the development of systems and processes that support patients in
ways consistent with these values.
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Pedometer as Adjunctive Therapy to Cardiac Rehabilitation
Program: A Feasibility Study
YMW CHOW, DBL TAN, S TONY, CSC SOH, CP WONG, JKK LOH,
HH HO, D FOO
Cardiac Rehabilitation Centre & Department of Cardiology, Tan Tock Seng
Hospital, Singapore

Conclusion: Our preliminary experiences showed that the use of pedometers
as adjunctive therapy to CRP is feasible and may have a beneficial effect on
the waistline. It may potentially be used as a motivational tool for physical
activity behaviour. Further studies in a larger patient population is necessary
to validate and expand its role in CRP.

Objectives: The prevalence of sedentary lifestyle is elevated after acute
coronary syndrome (ACS). Recent studies have shown that a physical activity
target of 7500-10,000 steps a day is a realistic goal for patients with ACS
and can help them reduce their burden of cardiovascular risk factors.
Pedometers have become popular tools for setting fitness goals and we
studied the feasibility of including pedometers as adjunctive therapy in ACS
patients undergoing cardiac rehabilitation program (CRP).
Methods: From June to July 2012, 8 eligible patients (7 male, mean age of
63.8±6.3 years) were introduced to the use of pedometer as adjunctive therapy
(Group A) to CRP at our institution. They were instructed to achieve a set
goal of at least 7500 steps per day. Serial assessment at baseline and at the
end of CRP included body mass index (BMI), waist to hip ratio and exercise
capacity (6 minute walk test). Nine other patients were identified and matched
as a control group (Group B).
Results: At baseline, there was no significant difference in demographic
data, risk factor profiles and mean ejection fraction between both groups.
After 6 weeks, there was no significant change in the BMI and exercise
capacity between both groups. However, there was a trend towards a much
lower waist-to-hip ratio (-3%; p=0.08) for Group A patients when compared
to Group B patients.

12.
Effects of Rosuvastatin and Atorvastatin on Coronary Artery
Disease Patients After Stent
Z TIAN, FF WU, XQ ZHENG
Chongqing Zhongshan Hospital, China
Objectives: To observe the effects of rosuvastatin and atorvastatin on
coronary artery disease patients after coronary stent.
Methods: 138 patients were randomized to Group A (n=68), atorvastatin
20 mg/d and Group B (n=70), rosuvastatin 10 mg/d, both groups were treated
for 2 years. The levels of TC (Total Cholesterol), LDL-C (Low-Density
Lipoprotein Cholesterol, TG (Total Glycerin), HDL-C (High-Density
Lipoprotein Cholesterol), hs-CRP (high-sensitivity C-reactive protein) and
cardiovascular events were observed after treatments.
Results: After 2 years treatments, TC, LDL-C, TG, hs-CRP in group A were
decreased [(5.92±0.93) mmol/L to (4.13±0.70) mmol/L, (3.69±0.62) mmol/L
to (2.51±0.46) mmol/L, (2.87±0.79) mmol/L to (2.32±0.65) mmol/L (5.86±
1.84) mg/L to (2.27±0.97) mg/L, all P<0.01], TC, LDL-C, TG, hs-CRP in
group B were decreased [(5.94±0.92) mmol/L to (3.89±0.75) mmol/L,
(3.71±0.61) mmol/L to (2.08±0.45) mmol/L, (2.87±0.79) mmol/L to (2.30±
0.62) mmol/L, (5.84±1.88) mg/L to (2.14±0.99) mg/L, all P<0.01], between
two groups,differences were found in TC levels (P<0.05), significant
differences were found in LDL-C levels (P<0.01), no differences were found
in TG and hs-CRP levels (P=0.39, P=0.18); HDL-C in group A were increased
[(0.85±0.19) mmol/L to (0.87±0.16) mmol/L, P=0.53], HDL-C in group B
were increased [(0.87±0.24 mmol/L to (0.97±0.18) mmol/L, P<0.01],
between two groups, significant differences were found in HDL-C levels
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(P<0.01); 32 patients in group A were rehospitalization because unstable
angina pectoris after coronary stent (47.06%), 22 patients in group B were
rehospitalization because unstable angina pectoris after coronary stent
(31.43%),cardiovascular events were no differences between two groups
(P=0.174).
Conclusion: The efficacy of rosuvastatin in reducing TC, LDL-C and in
increasing HDL-C excelled atorvastatin; the patients in group B have little
cardiovascular events than group A.
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Systolic Blood Pressure Recovery after Graded Exercise Test: Left
Ventricular Ejection Fraction and Medication
SH YANG,1 LW HSIEH,1 CC SHEN,1 WC LIN,2 W CHOU1
1
Department of Physical Medicine and Rehabilitation, Chi Mei Hospital,
Chiali; 2Department of Physical Medicine and Rehabilitation, Chi Mei
Medical Center, Tainan, Taiwan

differences of age, gender, α or β blocker use, comorbidities between two
groups.
Conclusions: Previous study had showed that delayed recovery response is
the predictors of more severe CAD, high risk of stroke and cardiac infarction
in normal population. In our study, only CAD patients were included and
we found that delayed recovery response was associated with poorer LVEF
despite of α or β blocker use.

Objectives: Our study is to investigate the relations between delayed blood
pressure recovery response after graded exercise test and left ventricular
ejection fraction (LVEF) in the cardiovascular disease (CAD) patients. We
also discuss the relationship between blood pressure recovery and their
cardiovascular medications.
Methods: Subjects received graded exercise test and measured blood pressure
via mercury sphygmomanometer. We measured blood pressure at the timing
of exercise peak, one minute after exercise peak, two minutes after exercise
peak, and three minutes after exercise peak, respectively. If subjects' 3 min
after peak to peak systolic blood pressure ratio was greater or equal to 0.93,
we defined them as "delayed recovery response". Then, we compared the
ejection fraction of left ventricle and medication between two groups. SPSS
version 15.0 for windows was used for statistical analyses. Categorical
variables were compared using either chi-square or Fisher exact test as
appropriate. Continuous variables such were compared using either
independent t test. A p value less than 0.05 were determined as significant.
Results: 153 CAD patients referred from cardiologist or cardiac surgeons
in our hospital were assessed. Exclusion criteria include heart transplant
receiver, no sufficient data, and no cardiac echogram in our medical records.
Then total 55 patients were included in our study. Delayed recovery group
had poorer LVEF (44.68±19.92 vs.63.22±15.27, p<0.001). There are no

14.
Quality Assurance of Cardiopulmonary Exercise Testing:
Experience in Taiwan
WY HSU,1,2 SY CHEN,1 C LAN,1 HP LEE,1,3 CJ HSU,1,4 JS LAI1
1
Department of Physical Medicine and Rehabilitation, National Taiwan
University Hospital, Taipei; 2 Department of Physical Medicine and
Rehabilitation, Taipei Medical University-Wan Fang Medical Center, Taipei;
3
Department of Physical Medicine and Rehabilitation, National Taiwan
University Hospital Yun-Lin Branch, Yun-Lin; 4Department of Physical
Medicine & Rehabilitation, Keelung Hospital, Department of Health
Executive Yuan, Keelung, Taiwan
Purpose: In recent years, findings of cardiopulmonary exercise testing have
been widely used in clinical diagnosis, assessment of treatment outcome,
prognosis prediction, exercise prescription and research purposes. However,
the testing equipment, calibration procedures, testing personnel, exercise
protocols, and results interpretation are different among hospitals in Taiwan.
The purpose of this study is to provide a quality assurance protocol for
measurement of oxygen uptake that can be utilized to reduce technical and
operational variability, and to validate this protocol.
Materials and Methods: From September 2009 to January 2011, forty
healthy men who received CPET in National Taiwan University Hospital
were assessed retrospectively. These forty men were 20-60 years of age,
with a body mass index between 19 and 25, and tested using ramp protocol
of 20 watt/min increment. The values of oxygen uptake were collected at
20, 40, 60, 80, 100, and 120 watt as reference values for quality assurance
protocol. We invited five hospitals for validation of the reference values.
Each hospital collected the oxygen uptake values of two healthy volunteers
who were conforming to the same inclusion criteria.
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Results: The oxygen uptake reference values at 20, 40, 60, 80, 100, and 120
watt were 9.44±1.27, 11.25±1.41, 14.12±1.88, 16.83±1.84, 20.02±2.47, and
23.00±3.15 mL/kg/min. The oxygen uptake data from cardiopulmonary
exercise testing in the invited hospitals were all within two standard
deviations of mean from reference values except for one hospital. After
thorough equipment calibration and replacement of the sampling tube, the
oxygen uptake data in the above-mentioned hospital passed the quality
assurance protocol.
Conclusions: The quality assurance protocol and reference values of this
study can be used for regular quality assurance of oxygen uptake
measurement by cardiopulmonary exercise testing laboratories in Taiwan,
as well as the ones from the Chinese. The protocol can be used as a quality
assurance protocol in multi-center clinical trials in the future.
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Differences between Australia and Thailand Cardiac
Rehabilitation Model of Care − A Review
W LAKSANAKORN, T LAPRATTANAGUL
Golden Jubilee Medical Center, Mahidol University, Thailand
Objectives: The objectives of this review were to explore the differences
between Australia and Thailand cardiac rehabilitation model of care with a
specific focus on interventions that could be adapted to meet the cultural
appropriateness of the Thai health system and to provide recommendations
for improving cardiac rehabilitation programs in Thailand in the most
effective manner for Thai socioeconomic status.
Methods: Review of trials reporting cardiac rehabilitation was an outcome
measure. Electronic database (PUBMED) was searched from 1 January 1999
to 30 May 2011 in the English language. Inclusion criteria were: cardiac
rehabilitation, cardiac rehabilitation model of care and cardiac rehabilitation
guidelines in Thailand and Australia.
Result: There was limited evidence-based data about cardiac rehabilitation
program efficacy, cost effectiveness and participation rates in Thailand. Most
cardiac rehabilitation programs in Thailand were based on programs of low
to moderate intensity exercise and group education, similar to Australia model
which was found to be cost effective and safe from several studies. There
were a limited number of health professionals in Thailand. Therefore it was
important for staff to develop proper competencies to cover other team
member roles if necessary to achieve multidisciplinary team approach.
Difference from Australia model of care, self-management concepts and
motivational interviewing have not been used generally in disease
management in Thailand. Professional training should be developed and

these concepts should be encouraged to use. There were separate exercise
classes for specific groups in Australia while there was no such a class in
Thailand model. Specific groups of patients should be prescribed separately
in the cardiac rehabilitation session, such as heart failure and young patients.
Community based cardiac rehabilitation program was rarely arranged in
Thailand, while this program was widely used and shown effectiveness in
Australia. Community based program should be implemented in Thailand
to decrease barriers in Thai patients to participate in the program.
Conclusion: There were differences in the cardiac rehabilitation program
between Australia and Thailand. This review provided recommendations
for delivering cardiac rehabilitation program in the most effective and
appropriate manner for Thailand's socioeconomic status, based on Australia
cardiac rehabilitation model of care.

16.
Meta-analysis of Complication as a Risk Factor for Early
Ambulation after Percutaneous Coronary Intervention
K KIM,1 K KIM,2 S WON,2 J KIM,3 E LEE,4 S PARK2
Department of Nursing, Changwon National University, Changwon;
2
Chung-Ang University, Seoul; 3Department of Nursing, Hallym Polytechnic
University, Chuncheon; 4Chung-Ang University Hospital, Seoul, Republic
of Korea

1

Purpose: This study systematically examined previous studies on the effect
of early ambulation on the vascular complications in subjects following
percutaneous coronary intervention (PCI), and analyzed the effects of early
ambulation on hemorrhage and hematoma formation at the puncture site.
Methods: Data were analyzed using the R (version 2.13.1) program.
Publication bias was verified via regression analysis using the logarithm of
the odds ratio (OR) and sample size, and a funnel plot using sample size.
The risk ratio of the incidence of bleeding and hematoma formation at the
puncture site relative to early ambulation was confirmed using ORs and the
forest plot.
Results: The bed rest time had no significant effect on the risk ratio of
hematoma formation [OR=0.89; 95% confidence interval (CI)=0.68-1.17]
or the incidence of bleeding (OR=1.14; 95% CI=0.77-1.7) at the puncture
site.
Conclusions: The findings of this study show that early ambulation following
PCI had no effect on the incidence of hematoma formation and bleeding at
the puncture site. However, differences in demographic factors should be
considered carefully in order to avoid interpreting the results too broadly.
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Epidemiological Profile of Coronary Heart Disease in India
DS BAIS,1 C YANG,1 W HASSAN2
1
Union Hospital, Tongji Medical College, HUST; 2Huazhong Agriculture
University, China
Background: Coronary Heart Disease (CHD) is the leading cause of death
in India and its contribution to mortality is rising. It's a narrowing of the
small vessels that supply blood and oxygen to the heart. Study aim was to
quantify the epidemiology of Coronary Heart Disease in India.
Methods: Epidemiological studies on Coronary Heart Disease had a
significant impact on its research, care and prevention in the last decades.
Southeast Asia region especially India has been considered to be the major
risk of Coronary Heart Disease. Data were obtained through a compressive
review using the MEDICINE and BIREME bibliographic database. In
addition, conference reports and government publications were identified
by government and nongovernment organization and other institutions.
Result: With 7.2 million deaths and 12.2% of total deaths, CHD is a
worldwide disease. CHD is assuming serious dimension in India. It is
expected to be the single most important cause of death in India by the year
of 2015. In 2005 the prevalent rate of CHD in urban areas as 6.4% and 2.5%
in rural areas. In urban areas the pooled estimate was 6.1% for males and
6.7% for females. In rural areas the estimate was 2.1% for males and 2.7%
for females. With a total of 29.8 million affected (14.1 million in urban
areas and 15.7 million in rural areas) according to the population-based
cross-sectional surveys. In 1990, there were an estimated 1.17 million deaths
from CHD in India, and now its double to 2.03 million by 2010. According
to medical certification of cause of death data, 25.1% of total deaths in
urban areas are attributable to disease of the circulatory system. Therefore,

it was assumed that mortality rates due to CHD in rural areas are expected
to be half of CHD specific mortality rates in urban areas.
Conclusions: Incidence of CHD is greater in urban areas than in rural areas
reflecting the acquisition of several risk factors such as tobacco consumption,
lack of physical activity, unhealthy diet and obesity. The vast majority of
the populations in India are at risk of developing CHD because of higher
than optimal levels of main risk factors.

18.
R e s u l t A s s e s s m e n t Te n Ye a r s C h i l d re n w i t h D i l a t e
Cardiomyopathy in Heart Hospital of Shahiad Rajaee Tehran
S MOLAEE,1 Z AMIRIMOGHADAM,2 ND NAYERI2
1
Faculty of Nursing and Midwifery, Tehran University of Medical Sciences;
2
Pediatric Cardiology Department, Imam Hossein Medical Center, Shahid
Beheshti University of Medical Sciences, Tehran, Iran
Background and Objectives: The most common disease associated with
heart dysfunction is cardiomyopathy especially dilated type. Its prevalence
is 36/5 in 10,000. This has a high mortality rate. Fifty percent of patients
have a 5-year survival and 25% of them have 10 years. Hereditary factors,
unknown and acquired are the causes of the disease. Therefore, this study
was conduct for assessing of clinical symptom and laboratory indexes,
prognosis, complications, treatment and mortality in patients with
cardiomyopathy in 10 years.
Method: In this retrospective descriptive study, all patients discharged with
final diagnosis of dilated cardiomyopathy who had referred to Rajai hospital
during 10 years were studied.
Results: The fifty-four percent (54%) of patients were girls. Their mean age
was 7.5 years. The most common ages who were referred was 3-4 years old.
Average number of hospitalized was four times for each patient. Forty percent
of patients were born in Tehran. The most common reason for referring
(70%) was dyspnea. The most common clinical finding that reported was
systolic murmur 3/6 in the left corner of Sternum (65%). The most common
blood group of patients (52%) was B+. In a radiological findings (CXR),
the most common symptom was big heart and the most important
echocardiograph findings, was left ventricular dilatation (57%). The most
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important finding in the catheterization, was the reduced left ventricle
contractility (EF=35%). The most common complication in patients was
mitral valve regurgitation (24%) and left heart failure (22%). The embolism
was reported as rare complication. In the relationship of prescribed
medications and prognosis, digitalis compounds, Lasix and Aldacton were
most prescribed medications that, two of whom died. For 19 patients, the
three above drugs was administered with Hydralazyn that one of them had
died. Course of the disease in this study showed that 42 patients (48%) were
full recovery, 34 (38%) partial improvement and 8 patients were died. The
average age of death, was 2.5 years. This study showed that the age of patients
is higher, the mortality rate was reduced and heart failure is less. It is possible,
blood group type of people, overcrowded environments and air Pollution
influence on cardiomyopathy dilatation. Also, medicines prescribed can be
effective in the prognosis of patients and their mortality rates. It is
recommended that more studies be done about "the relationships of above
variables with the prevalence or prognosis of dilated cardiomyopathy.
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Cardiac Manifestations of Classic Rheumatological Conditions:
A Narrative Review
MB OWLIA,1 SMY MOSTAFAVI POUR MANSHADI,2 N NADERI2
1
Department of Rheumatology, Shahid Sadoughi Hospital, Shahid Sadoughi
University of Medical Science; 2Member of Research Group of Shahid
Sadoughi University of Medical Science and Ali ben Abitaleb Medical
College (Islamic Azad University), Yazd, Iran
Cardiovascular diseases are common in systemic rheumatologic diseases.
They can be presented at the time of diagnosis or after diagnosis. The cardiac
involvements can be the first presentation of rheumatologic conditions. It
means that a patient with rheumatologic disease may go to a cardiologist
when attacked by this disease for the first. These manifestations are very
different and involve different structures of the heart, and they can cause
mortality and morbidity of patients with rheumatologic diseases. Cardiac
involvements in these patients vary from subclinical to severe manifestations.
They may need aggressive immunosuppressive therapy. The diagnosis of
these conditions is very important for choosing the best treatment. Premature
atherosclerosis and ischemic heart disease are increased in rheumatoid
arthritis and systemic lupus erythematosus, and may be a cause of mortality
among them. The aggressive control of systemic inflammation in these
diseases can reduce the risk of cardiovascular disease especially ischemic
heart disease. Although aggressive treatment of primary rheumatologic
diseases can decrease mortality rate and improve it, at this time, there are no
specific guidelines and recommendations, to include aggressive control and
prevention of traditional risk factors, for it.

20.
Comparison of Outcome Measures of 6 Versus 10 Exercise
Sessions in Cardiac Rehabilitation
CSC SOH, S TONY, DBL TAN, YMW CHOW, CP WONG, JKK LOH,
HH HO, D FOO
Cardiac Rehabilitation Centre & Department of Cardiology, Tan Tock Seng
Hospital, Singapore
Objectives: Cardiac Rehabilitation Program (CRP) is a multi-disciplinary
program that has been shown to lower patients' risk of adverse cardiovascular
events and mortality. It improves functional capacity, psychological wellbeing, quality of life and cardiac risk factors. We examined the differences
in outcome measures between 6 and 10 exercise sessions within a 6 week
period of CRP.
Methods: This is a retrospective study evaluating 254 patients with the
diagnosis of coronary artery disease (CAD) who completed CRP (by choice
of either 6 or 10 exercise sessions) at our institution from 2009-2011. They
either received medical therapy or coronary revascularisation (percutaneous
coronary intervention or coronary artery bypass graft) for the underlying
CAD. Each exercise session consisted of 45 minutes of aerobic exercise
and 10 minutes of resistance training (with 10 minutes each for warm up
and cooling down). The aerobic training was initiated at 10% lower than the
maximal heart rate achieved during the submaximal exercise bicycle test.
The work rate was then gradually increased towards 80% of age predicted
maximal heart rate.
Results: Seventy patients (28%) chose to undergo 6 sessions of CRP whereas
the remaining 184 chose 10 sessions. The baseline demographics, risk factor
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profiles and mean ejection fraction were similar in both groups. For both
groups, the majority of the patients were Chinese (77.2%) and there were
male predominance (91.3%). For the overall study group, there were
significant improvement in fat percentage (-1.3%; p=0.02) and exercise
capacity (+17%; p<0.01) after cardiac rehabilitation. The exercise capacity
was significantly higher in the 10 session group (13.6±18.8 watts vs
7.9±12.6 watts; p=0.02) when compared to the 6 session group.
Conclusion: Patient with CAD demonstrated significant improvements in
fat percentage and exercise capacity after a short stint of CRP. The exercise
capacity was significantly higher in the 10 exercise session group, thus
confirming the dose-response beneficial impact of physical activity.
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Assessment of Periodontal Risk Factor for Atherosclerotic
Cardiovascular Disease in Geriatric Patients
UK SHET, HJ KIM, SW LEE
Department of Periodontics and Dental Education, School of Dentistry,
Chonnam National University, Gwangju, South Korea

pathogen strongly implicated in ACVD may serve as a good indicator for
assessing periodontal condition in geriatric patients. These results therefore
suggest that in geriatric patients the level of P. gingivalis should be closely
monitored, and this may lead to reducing potential risk factors for the
development of ACVD. A regular periodontal checkup for geriatric patients
with high risks of ACVD is strongly recommended.

Objectives: Numerous data have supported an association between
periodontal disease (PD) and atherosclerotic cardiovascular disease (ACVD).
Possible mechanisms proposed for this link include a host-parasite interaction
resulting in chronic inflammation that is initiated by periodontal pathogens,
such as Porphyromonas gingivalis. The purpose of this study was to assess
periodontal risk factors implicated in ACVD in geriatric patients by
characterizing periodontal pathogens.
Methods: Six periodontal pathogens present in saliva were quantified by
using real time PCR in geriatric patient groups with PD (>60 years): mild
(MCP), moderate (MoCP), and severe chronic periodontitis (SCP). The copy
numbers of P. gingivalis, Tannerella forsythia, Treponema denticola,
Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum and
Prevotella intermedia were measured and compared among the groups.
Results: The results showed that bacterial copy numbers of tested periodontal
pathogens increased as the severity of disease increases, except for
P. intermedia. Significantly high numbers of P. gingivalis, T. forsythia,
T. denticola and F. nucleatum were found in SCP than MCP. P. gingivalis,
T. denticola and F. nucleatum showed significantly higher levels in MoCP,
compared to MCP.
Conclusion: Collectively, results of this study suggest that the levels of
P. gingivalis, T. forsythia, and T. denticola were increased as the severity of
periodontal disease increases. It was found that P. gingivalis, a periodontal

22.
The Change of Smoking Behavior and Adherent to Preventive
Guidelines after Heart Attack
JS PARK,1 SH LEE,1 DG SHIN,1 YJ KIM,1 MH JEONG,1 YK AHN,2 MC
CHO,3 JW BAE,3 CJ KIM,4 JM CHO,4 KR HAN,5 JH LEE5
1
Yeungnam University Medical Center, Daegu; 2Chonnam University
Hospital, Gwangju; 3Chungbuk University Hospital, Chungju; 4Kyunghee
University Hospital, Seoul; 5Hanrim University Hospital, Seoul, Korea

independent predictor for smoking cessation (RR 1.230, p=0.022). On the
other hand, continuous smoking was not the independent predictor of reintervention or myocardial infarction at 1 year.
Conclusions: Only small percentage of MI patient adherent to guidelines
for the secondary prevention. Furthermore, quite a few of smokers failed to
quit smoking, therefore we need an effective patient education system to
help them.

Background and Objectives: Risk factor modification is the key preventing
subsequent cardiac events after heart attack. This study was designed to
investigate the gap between preventive guidelines and clinical practice in
smoking patients
Materials and Methods: The study was carried out in smokers who admitted
with heart attack at 5 university hospitals in Korea. Total 275 patients who
were on the regular follow up for more than one year after myocardial
infarction (MI) were randomly selected and enrolled in this study. We
investigated the change of smoking behavior and adherence rate to the ACC/
AHA guidelines for the secondary prevention in patients with coronary artery
disease, at the time of and 1 year after the event.
Results: The patients consisted of 267 males (97.1%) with a mean age of
57.0±11.2 years. The patients achieved target goals at one year were as
follow; smoking cessation 51.3%, blood pressure 83.9%, HbA1C 32.7%,
lipid 65.5%, body mass index 50.5%. Only 58.8% of the patients attempted
to quit smoking and 45% of them started smoking again within 1 month
after discharge. There was no previous smoking pattern (smoking onset age,
amount and duration) associated with success or failure of quitting smoking.
From the multivariate logistic analysis including smoking patterns and
clinical characteristics, severity of coronary artery disease was the only
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The Benefits of Telephone Counselling on Smoking Cessation
Intervention
SY YAU, YL CHEUNG
Open University of Hong Kong, Hong Kong
Objective: Smoking is one of the leading causes of death worldwide.
According to the World Health Organization (WHO), six million people are
killed by smoking including smokers, ex-smokers, and second-hand smokers.
There is an alarming estimation that more than eight million annual deaths
will be caused by smoking in year 2030. Also, the cardiovascular health
risks of smoking on individuals' health are well documented. Due to the
health hazards of smoking, telephone counselling is introduced as one of
the smoking cessation interventions to encourage individuals to seek
cessation services. The objective of the current study is to provide an
overview of the benefits of telephone counselling on smoking cessation
intervention.
Methods: A systematic literature review was conducted using Medline,
PubMed, and Embase. With the use of keywords search, articles focused on
the benefits of telephone counselling on smoking cessation were included.
The results were analyzed and summarized.
Results: Telephone counselling was reported to be an effective and
economical smoking cessation intervention. Many (60-80%) of the
individuals who joined the telephone counselling services were able to follow
up. There were about 30-55% individuals showed positive smoking cessation
rate in six months post-program follow up when comparing to the control
groups of about 2-12%. Telephone counselling provided a channel for the
provision of and enhancing the effect of tailor-made printing materials when

participants required for additional information during the counselling
services. Telephone counselling could also strengthen the pharmacotherapy
adherence among the participants who were reported to request for further
pharmacotherapy intervention apart from receiving telephone counselling.
Conclusion: The benefits of telephone counselling on smoking cessation
intervention are well supported. With the high mortality and health hazards
of smoking, telephone counselling provides an effective means for
encouraging smoking cessation.

24.
Evidence for Association of the Sleep Duration and Hypertension
in the Young and Middle-aged Women but not Men and Old
Women
I KIM
Samsung Seoul Hospital, Korea

Conclusion: In a Korean nationwide population-based sample, there is
evidence for association of short sleep duration with an increased risk of
hypertension, only among the young and middle-aged women aged <65
years.

Objectives: Various studies have reported short sleep duration is
associated with hypertension in western countries. Recent studies show
that sleep deprivation may be associated with an increased risk of
hypertension with possibly stronger effects among women than men. This
study assesses age & sex-specific relationship between sleep duration
and hypertension in Korean population.
Methods: We analyzed 7178 participants from age 19 to 99 years. The
data were obtained from the Fourth Korea National Health and Nutrition
Examination Survey conducted in 2008. Self-reported sleep duration was
categorized into 5 groups. In this cross-sectional study, logistic regression
was used to test the hypothesis that short sleep duration is associated
with increased risk of hypertension.
Results: Sleep duration less than 6 hours was associated with increased
risk for hypertension in the young and middle-aged women aged <65
years, (OR 1.89, 95% CI 1.23-2.91) after adjusting for multiple variables
when 7 hours of sleep was used as a reference for sleep duration. There
was no statistically significant correlation between sleep duration and
hypertension in men & old-aged women aged <65 years.
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Association between Vitamin D Status and Chd Risk Assessed by
Framingham Risk Score in Korean Population

Estimation of Coronary Heart Disease Risk Factors in Diabetic
and Non-Diabetic Patients in Qazvin City, Iran

SJ KIM, Y S PARK, HM NOH, IH KIM, JH YOO
Department of Family Medicine, Samsung Medical Center, Sungkyunkwan
University School of Medicine, Korea
Objectives: Vitamin D has been suggested to be associated with coronary
heart disease (CHD) risk. In this study, we evaluated the association between
vitamin D status and CHD risk assessed by Framingham risk score (FRS) in
Korean population.
Methods: Cross-sectional analysis of data from the Korean National Health
and Nutrition Examination Survey V-1, 2010 was used to examine the
association between serum 25-hydroxyvitamin D(25(OH)D) levels and the
10 year CHD risk assessed byFramingham Risk Score in a representative
population-based sample of 8958 men and women aged 30 to 74 years.
Results: The prevalence of high risk group of CHD was 9.6% (SE 0.8) and
2.0% (SE 0.3), respectively.The prevalence of vitamin D deficiency (25(OH)
D <20 ng/mL) was 58.3% of male and 74.0% of female subjects.The analysis
has been stratified by sex due to CHD risk difference between males and
females. Since Vitamin D deficiency had widespread distribution over all
subjects, in this study, we classified vitamin D deficiency into 4 groups such
as 25(OH)D <10ng/mL (group A), 10 ng/mL ≤25(OH)D <15ng/mL (group
B), 15 ng/mL ≤25(OH)D < 20 ng/mL (group C) and normal group D. In case
of men,the lowest category of 25(OH)D (<10 ng/mL) had an increased risk of
CHD(OR=2.39 95% CI1.05-5.43), compared with the highest 25(OH)D
category (≥20 ng/mL). However, in case of women, any significant association
between 25(OH)D levels and CHD risk has not been observed in this study.
Conclusion: The present study suggests there is a significant association
between vitamin D status and coronary heart disease risk in Korean male
population.

G AZAM
Metabolic Diseases Research Center, Qazvin University of Medical Science,
Iran
Background: Diabetes is a chronic disease. Patients with diabetes mellitus
are high risk for coronary heart disease.
Materials and Methods: A cross-sectional study was designed. One
hundrred diabetic patients were compared to 140 non-diabetics who were
visited in metabolic diseases clinic at Qazvin, Iran in 2010. The study groups
were interviewed through structured questionnaire containing clinical,
anthropometric and laboratory questions. Data were gathered by trained
nurses and analyzed statistically.
Results: Mean age of the patients was 46.25±1.54 VS 45.71±1.01 in case
VS control groups. Overall, 42% of population was with diabetes mellitus
and 58% were non-diabetic. There were significant differences between two
subgroups in some variables include BMI, triglycerides, SBP, DBP, height,
waist circumference/hip, hypertension, dyslipidemia and family history of
diabetes (P<0.05). Some risk factors showed a significant difference between
two groups too.
Conclusion: Results of present study are crucial for healthcare professionals
and authorities. Lifestyle intervention programs should be focused on
community education about reduction of CHD risk factors in diabetic
patients. It is recommended that programs would be arranged with emphasis
on primary and secondary prevention of blood glucose elevation and other
risk factors for coronary heart disease in high risk individuals.

27.
Clinical Verification for Restenosis Despite Cardiac Rehabilitation
after PCI
Z IHARADA, J IWASAKA, M KUBOTA, Y KIMURA, I SHIOJIMA
The Department of Cardiology, Nephrology, Endocrinology and Metabolism,
Kansai Medical University Takii Hospital, Japan
Secondary prevention for myocardial infarction is one of the most important
therapeutic target in ischemic heart disease (IHD). Cardiac rehabilitation is
well recognized as one of the safe and effective therapy for secondary
prevention of IHD. We present 4 patients (a 66-year-old female, a 58-yearold male, a 77-year-old male and a 59-year-old male) who were hospitalized
with acute myocardial infarction (AMI). Urgent percutaneous coronary
interventions (PCI) were performed. After PCI, they were enrolled to cardiac
rehabilitation program with exercise training for 6 months. However,
coronary angiographical examinations performed 6 months after urgent PCI
revealed severe restenosis in their target lesion sites, we found no worsening
in their exercise tolerance and no evidence of recurrence of cardiac ischemia
or infarction. Cardiac rehabilitation with exercise training might be safe
and effective to maintain their cardiac ischemic condition even in the cases
with restenostic lesion after PCI.
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1.
Cardiac Rehabilitation is Yesterday's Service − Tomorrow's is
Preventive Cardiology
DA WOOD
International Centre for Circulatory Health, Imperial College London, UK
Cardiac rehabilitation has an honourable tradition of rehabilitating those
who have suffered a myocardial infarction or following cardiac surgery.
The evidence base for this service is strong with meta-analyses of randomised
controlled trials reporting a reduction in total mortality and cardiovascular
mortality, although no reduction in recurrent myocardial infarction or the
need for revascularisation. In contrast a systematic review of secondary
prevention programmes found a reduction in the risk of recurrent myocardial
infarction and hospitalisations. However, this distinction between cardiac
rehabilitation and secondary prevention is artificial as patients require a
comprehensive programme which addresses lifestyle as a whole together
with effective risk factor management and appropriate use of cardioprotective
drug therapies. The European guidelines define priority patient groups as
(1) patients with established atherosclerotic disease (coronary artery disease;
cerebral arterial disease; peripheral arterial disease); (2) asymptomatic
individuals who are at high risk of developing atherosclerotic disease because
of (i) multiple risk factors resulting in a ten year risk of >5% for developing
a fatal cardiovascular disease (CVD) event (ii) markedly raised levels of
single risk factors including familial dyslipidaemia and severe hypertension
(iii) diabetes mellitus; and (3) close relatives of patients with early onset
atherosclerotic disease and asymptomatic individuals at particularly high
risk. A modern preventive cardiology service should provide an integrated
programme for secondary and primary prevention of CVD which addresses
all these priority groups. The aim is to help patients with established
atherosclerotic cardiovascular disease, and those asymptomatic individuals

at high risk of developing cardiovascular disease, to reduce their overall
risk of CVD, improve their quality of life and life expectancy. The goals of
such a programme are to stop smoking, make healthy food choices and be
physically active with a BMI goal of <25 Kg/m 2 and a normal waist
circumference. The blood pressure goal is <140/90 mmHg. The lipid goal is
a total cholesterol <3.0 mmol/l and LDL cholesterol <1.8 mmo/l for patients
with established atherosclerotic disease, asymptomatic individuals with a
very high CVD risk (fatal CVD >10% over 10 years) and for patients with
diabetes with multiple risk factors or target organ damage. Beyond the use
of drugs to lower blood pressure and lipids the appropriate use of other
cardio-protective drug therapies is also recommended. The EUROACTION
model of preventive cardiology set a new standard for preventive cardiology
practice in hospital and primary care. MyAction is an evolution of
EUROACTION for the National Health Service in England which integrates
secondary and primary prevention in a community setting. This nurse-led,
multidisciplinary, family centred, preventive cardiology programme is
achieving healthier lifestyles for patients and families, together with
improved risk factor control and a better quality of life.

2.
Cardiovascular Risk Factors in Hong Kong
BMY CHEUNG
Sun Chieh Yeh Heart Foundation Professor in Cardiovascular Therapeutics,
Division of Clinical Pharmacology, Department of Medicine, University of
Hong Kong, Hong Kong
The Interheart Study showed clearly that nine major risk factors account for
most of the myocardial infarctions worldwide, although in each country or
region, the relative prevalence of these risk factors may be different. These
nine risk factors are: abnonnal apolipoprotein B/apolipoprotein A-I (ApoB/
ApoA-l) ratio, cigarette smoking, diabetes, hypertension, abdominal obesity,
psychosocial stress, lack of exercise, unhealthy diet and no alcohol intake.
It is worth noting that most of these are affected by lifestyle and genes have
only a modest influence. In Hong Kong, smoking and alcohol drinking are
not very prevalent. Therefore, the major opportunities for intervention are
dyslipidaemia, diabetes, hypertension, abdominal obesity, exercise and diet.
The Hong Kong Cardiovascular Risk Factor Prevalence Study (CRlSPS)
cohort is a population-based prospective study that started in 1995-6, when
2895 subjects (1412 men and 1483 women), aged 25-74, were randomly
recruited from the general population. Subjects were invited for follow-up
in 2000-4 (CRlSPS2) and 2005-8 (CRlSPS3) to assess their cardiovascular
risk factors, including diabetes, hypertension and dyslipidaemia. CRlSPS4
is now underway. In CRlSPS, we could trace how the aforementioned risk
factors, namely, dyslipidaemia, diabetes, hypertension, abdominal obesity,
exercise and diet, developed in the cohort. Lack of exercise and a diet with
excessive calories and high glycaemic index lead to obesity, followed by
dyslipidaemia and then diabetes and hypertension. In other words, the person
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develops the metabolic syndrome. CRlSPS3 has yielded a number of
surprises. There was a striking increase in the prevalence of hypertension
and the prevalence of abdominal obesity in this cohort, but the BMI has not
increased, nor has the prevalence of diabetes. The increase in prevalence of
hypertension might be explained by the increase in abdominal obesity. Our
findings further confinn the importance of waist circumference in this
population; calculating the BMI alone may give a false sense of security.
The prevalence of hypertension in Hong Kong is now approaching the level
in developed countries such as the United States. Clinical trials show that
addressing obesity will reduce blood pressure and blood glucose. Current
efforts are channelled towards the detection and treatment of cardiovascular
risk factors in older adults. However, the rise in the prevalence of risk factors
with age means that preventive measures, such as a healthy diet and regular
physical activity, should start early in life.
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3.
Control of Risk Factors by Non-pharmacologic Interventions:
Role of Life Style Changes in the Prevention of CVD
M MARANHAO
Cardiology Department, Federal University of Parana Medical School and
Evangelic Medical School and Hospital, Brazil
A small percentage of the population spent the major part of the health-care
budget to address diseases related with an unhealthy behavior and lifestyle.
Those people are now sick due their way of life and not from diseases beyond
their control, like genetics and environment. Many studies states that 80%
of health-care budget by problems related with smoking, alcoholism,
psychological stress, unhealthy food and physical inactivity leading the
global pandemy of heart disease, diabetes, obesity and prostate/breast cancer,
which are largely preventable and even reversible by changing diet and
lifestyle. The majority of patients (PTS) with coronary artery disease (CAD),
shows coronary arteries with major obstruction which leads to acute coronary
syndromes, like myocardial infarction and sudden death. Procedures like
PTCA and By-Pass Surgery, costs over 100 billion of dollars annually only
in USA. In spite that, vein grafts, are generally blocked after few years and
the PTCA, only in few months. Generally, doctors recommends to the PTS
after those procedures to adopt an health lifestyle, to avoid new episodes or
to slow the progress of the disease, like to stop smoking, eat well, moderate
exercise and to coping with stress. Only 10% of them follow those
recommendations. Many people tend to think of breakthroughs in medicine,
as new drug or high-tech procedures in diagnosis and therapies, but often
forgot that simple choices that we make in our lifestyles, can be as powerful
as drugs and surgeries, an even better, at it was proved by Dean Ornish from
the Preventive Medicine and Research Institute (PMRI). These choices are
especially clear in Cardiology and large-scale studies have shown that

lifestyle changes could prevent at least 90-95% of all heart diseases, which
accounts for more premature deaths and costs worldwide. Recently, Dean
Ornish and associates of the UCSF, published the first study, showing that
lifestyle changes also may beneficially affect gene expression in only three
months, turning on genes that prevent disease and turning off genes that
promote heart disease and cancer. On the other hand, intensive lifestyle
changes significantly increase telomerase and the telomere length, which
are the ends of our chromosomes, that helping to control aging and the time
of life.

4.
Lipid Treatment Update
M HU, B TOMLINSON
Department of Medicine and Therapeutics, The Chinese University of Hong
Kong, Prince of Wales Hospital, Hong Kong
Statin therapy has become the mainstay of treatment for reduction of LDL
cholesterol (LDL-C) to reduce cardiovascular risk and more intensive statin
therapy provides additional risk reduction. Mono-therapy with statins may
be insufficient in subjects with very high baseline LDL-C and some patients
are intolerant of statin treatment or may have adverse drug interactions and
more intensive statin treatment is associated with a small increase in the
risk of developing diabetes. Combining statins with ezetimibe may result in
more effective reduction of LDL-C but whether this combination results in
improved outcomes compared to more intensive statin therapy remains to
be proven. New forms of therapy to reduce LDL-C with monoclonal
antibodies to PCSK9 or antisense oligonucleotides to Apo B-100 are currently
under development and can result in more effective reduction of LDL-C.
For patients with combined dyslipidaemia with elevation of triglycerides
and lower levels of HDL cholesterol there are the options of adding niacin
or fibrates. Beneficial effects have been seen in some outcomes with these
treatments and ongoing studies may help to define the role of niacin in
some patient groups. Some of these questions will be answered by the
ongoing studies but optimization of lipid-modifying treatment for individual
patients is likely to remain an uncertainty for many years to come. Statin
therapy is likely to remain the cornerstone of treatment, but combinations
with other drugs will become more popular.
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5.
Cardiac Rehabilitation Program for Patients after Coronary
Artery Bypass Grafting Surgery
SY CHEN, C LAN, JS LAI
Department of Physical Medicine and Rehabilitation, National Taiwan
University Hospital, and National Taiwan University, College of Medicine,
Taipei, Taiwan
Coronary artery bypass grafting surgery (CABG) and percutaneous coronary
intervention (PCI) are the most common methods of revascularization for
symptomatic coronary artery disease (CAD). These two interventions can
reduce ischemic symptoms such as angina or dyspnea, thus improving the
ability to undertake physical training. In general, CABG remains the method
of choice in patients with left main disease, multivessel disease, especially
in diabetic patients, or patients with left ventricular dysfunction, in the event
of failure of PCI, and in-stent restenosis. Although the procedure risk is
higher for patients receiving CABG, the extent of revascularization is more
complete, and hence the potential of training is higher than patients with
PCI. Short-term exercise training for patients with CABG showed benefits
to cardiorespiratory function, muscular strength, metabolic profile, cardiac
function, ventilatory threshold, hemodynamic function and quality of life.
Additionally, exercise training may improve graft patency, reduce cardiac
events and readmission rate. Thus, CR exercise training is an important
intervention and should be recommended to most of the patients after CABG.
Phase I cardiac rehabilitation (CR) delivers rehabilitative services to
hospitalized CABG patients following CABG. Phase I CR can decrease the
deleterious physiologic and psychological effects of bed rest, enable patients
to safely return to activities of daily living within limits, and facilitate patient
entry into an outpatient phase II CR program. The exercise training of phase
II CR improves exercise capacity, without significant complications or other

adverse effects. For patients with CABG, previous studies reported 10.5%48.2% increase of peak oxygen uptake in outpatient CR, and the increase of
absolute value was 1.9-6.6 mL/kg/min, depended on different exercise
protocol and the initial level of fitness. Tai Chi Chuan (TCC) is a popular
Chinese conditioning exercise. The exercise intensity of TCC was low to
moderate, depends on its training style, posture and duration. We have applied
a 12-month TCC program to patients with CABG as a phase III cardiac
rehabilitation program. After training, the TCC group showed an increase
of 10.3% in peak oxygen uptake and 11.9% in peak work rate. Therefore,
TCC may be prescribed as an alternative exercise program for selected
patients with CABG.

6.
Remote Medicine in Home Cardiac Rehabilitation by ICT
Y KIMURA
Health Science Center, Kansai Medical University, Japan
Cardiac rehabilitation basically consists of behavior medicine and based on
modification of life style such as exercise, food and smoking cessation. There
are some problems to achieve behavior medicine, since recording of the
patient's physical/vital data in daily life is not easy for long period and
simultaneously subsequent feed-back of those data are also more difficult.
However, ITC (Information Technology Communication) will make some
solutions of these problems. We developed ICT home monitoring system,
which obtain home vital data such as blood pressure, steps of walk and
body weight automatically through wireless gateway system and feed back
some messages to patients by e-mail for keeping of patient's positive daily
activity. Our study in metabolic syndrome subjects showed that the ICT
home monitoring group (body weight, steps, blood pressure) showed more
reduction of body weight compared with the subjects without home
monitoring. And the subjects with feed-back message showed highest
reduction of body weight. The subjects with myocardial infarction also
showed good control of body weight and blood pressure when followed by
ICT home monitoring system. These data showed ICT home monitoring
and feed-back would quite cost-benefit and effective system of cardiovascular
disease management. Now we are using real time ECG monitoring system
through just simple LAN and smart phone. These ECG data will be more
convenient and useful for not only emergency situation but also daily cardiac
monitoring. We will show the latest system for these cardiac monitoring
systems.
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7.

8.

The Safety of Exercise in Patients with Known Heart Disease

Cardiac Rehabilitation Issues: Return to Work

J LIM
Novena Heart Centre, Singapore

V KANTARATANAKU
Director, Rehabilitation Center, Samitivej Srinakarin Hospital; and Bangkok
Dusit Medical Services Public Company Limited (BDMS), Bangkok,
Thailand

Cardiac rehabilitation has been proven to be safe and beneficial to patients
who have underlying cardiovascular abnormalities. However, many such
patients may also be interested in participating in vigorous activities such
as competitive sports or marathons which would occur in an unsupervised
environment. Guidelines on whether such persons should consider doing
these activities remains nebulous at times. Many factors need to be considered
when making an assessment of safety. Persons who can be classified as
having underlying heart disease encompass a wide spectrum of risk. On
one hand we have persons who are asymptomaptic but have been found to
have sub-clinical atherosclerosis. They are generally at lower risk to those
with known coronary ischemia or critical valve abnormalities that have not
been reversed by medications or surgery. Another consideration beside the
person's underlying cardiac abnormality is the type of exercise for which
he/she plans to undertake. Exercise can generally be divided into dynamic
(isotonic) or static (isometric) although most exercise or sports encompasses
both components to varying degrees. The duration, intensity of exercise and
the environment in which it is conducted must also be factored in. Generally,
stress testing remains the main modality for assessment. During stress testing,
attention is paid to the presence of ischemia, the effort tolerance of the person,
the presence or absence of significant arrhythmia and the blood pressure
and heart rate response. However, stress testing often cannot replicate the
true stress that a person undergoes during competitive or endurance sports.
In conclusion, there are fundamental variables that should be considered
when deciding if patients are suitable to safety undertake strenuous activities.
The final decision should however be a choice made by patients themselves
after careful discussion with their physicians.

One of the main ultimate goals of a cardiac rehabilitation is to support the
patients in resuming to their normal life, and one important issue among
normal life is return to work. Patients with heart disease should be able to
return to their work safely after cardiac events. Is has been stated that patient
after acute myocardial infarction without any complication should safely
return to their previous works: light job after 2 weeks and 6 weeks for
strenuous job. In Europe and the United States, there were 60% and 93%
respectively for returning to work. Our data revealed that only 40 percent of
patient, who aged at or less than 60 years old, and needed to return to work,
was able to return to their work. The determinants of return to work are
severity and prognostic of heart disease, the residual loss of function after
heart disease. For individual consideration of return to work are incidence
of heart at work, psychological factors, age, type of job, and attitude of
involved personnel. Patients with heart disease who attend cardiac
rehabilitation program comprised of physical training, psychological support
and vocational counseling, demonstrated the higher rate of returning to work.
The review by Shepherd indicates that cardiac rehabilitation improves the
quality of life for coronary heart disease patients and that quality of life
improvements have a bi-directional relationship with increased physical
activity and vocational status. Return to drive as a job is differently and
there is no definite protocol for this issue. Exercise and functional testing
will have an important role in this situation. Three cases of patient will be
discussed: patient with unstable angina, patient with heart failure and patient
with implanted device.

9.
Tobacco Policies and Prevention of CVD in Asia
JL MACKAY,1 A GRAINGER-GASSER,2 M NAKAMURA,3 R GREENLAND,4
T DUNCAN5
1
Senior Advisor, World Lung Foundation and Director, Asian Consultancy
on Tobacco Control; 2Project Manager, World Heart Federation; 3Executive
Secretary, Asia Pacific Heart Network; 4Director, Government Relations,
National Heart Foundation of Australia and Secretary/Treasurer, Asia-Pacific
Heart Network; 5Chief Executive, New Zealand Heart Foundation and Board
Chairman, Asia Pacific Heart Network

reduce tobacco use, and a new paradigm is needed to combat the epidemics
of the 21st century. Proven, effective strategies to reduce the tobacco
epidemic are already known, and it only requires political will, with the
support of health professionals, to implement these.

In nations in which the tobacco epidemic has declined, in nearly all cases it
was physicians who led the way by changing their behaviour from being
one of the groups with the highest smoking prevalence to being one of, if
not the, lowest. Therefore, in any nation where the tobacco epidemic is still
large, focusing on reducing smoking among physicians and involving them
in tobacco control activities may be the most important action a national
tobacco control movement can take. Cardiologists have a critical role in the
tobacco epidemic. They have close contact with patients, are on the front
line of health care, are well respected and a trusted source of healthcare
advice, and should act as role models and exemplars for healthy behaviour.
To reduce cardiovascular disease (CVD) in Asia, CVD health professionals
will need to support on-going tobacco control measures at the population
level more strongly, especially the World Health Organization Framework
Convention on Tobacco Control (WHO FCTC), and particularly to advise
non-smokers to avoid second-hand smoke, and support smokers (and other
tobacco users) to quit. The traditional medical model will never be able to
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10.

11.

The Utilisation of Cardiovascular Imaging for Detection of Early
Atherosclerosis

How to Improve the Drug Compliance of Hypertensive Patients

C CHAN
Queen Mary Hospital, Hong Kong
Current guidelines for primary prevention recommend initial assessment
and risk stratification based on traditional risk factors (e.g. the Framingham
Risk Score [FRS] in the United States and the Systemic Coronary Risk
Evaluation in Europe), followed by goal-directed therapy as necessary to
modify those risk factors. However, these traditional prevention strategies
can be inadequate, as cardiovascular events do occur in patients without
known risk or in low and intermediate risk groups in whom an aggressive
treatment strategy would not be indicated. Thus, earlier detection of
anatomically or metabolically significant, but "subclinical" or "preclinical"
atherosclerosis may allow for more timely intervention that in turn may
prevent progression to symptomatic illness, vulnerable plaque formation or
sudden death. In this presentation, we will explore the current and potential
clinical roles of different imaging tools including Ultrasound, Computer
Tomography, and Magnetic Resonance Imaging on the detection of early
atherosclerosis.

CW LAM
Department of Cardiology, Alice Ho Miu Ling Nethersole Hospital, Hong Kong
Hypertension has become a major health burden worldwide in past decades.
Suboptimal blood pressure control in hypertensive patients can result in
detrimental clinical consequences such as myocardial infarction, renal
dysfunction and cerebrovascular accident. Studies have shown that poor drug
compliance is one of the key reasons for suboptimal blood pressure control.
Hence, improvement in drug compliance can certainly improves blood pressure
control. According to several large-scaled clinical trials, because of social
inconvenience, patients who require multiple anti-hypertensive drugs have
worse drug compliance than those who require single drug therapy only. For
the similar reason, complex therapy regimes (3-4 times per day) can also result
in poor drug compliance as patients tend to forget their mid day doses. In
order to overcome these obstacles, single pill combination (SPC) is a good
option to improve patients' drug compliance. SPC is generally well-accepted
by hypertensive patients as it can cut down their daily tablet number by 3-4
pills. Moreover, most of the SPC preparations in the market are in once-daily
basis. This certainly simplifies the therapy regime and provides patients with
a great deal of convenience. Last but not least, calcium channel blocker (CCB)
induced pedal edema, though harmless, can be very disturbing to hypertensive
patients. This side effect can be alleviated by an additional angiotensinconverting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB).
By using a SPC of both CCB and ARB, incidence of pedal edema is
significantly reduced when compared to CCB single therapy.
In 2009, European Society of Hypertension guideline has stated "When
possible, use of fixed dose (or single pill) combinations should be preferred
because simplification of treatment carries advantages for compliance of
treatment."

12.

13.

Prevention of Hypoglycemia − The Evidence of Incretin-based
Therapy

HDL-cholesterol − Risk Factor or Risk Target?

CH CHOI
Department of Medicine, Queen Elizabeth Hospital, Hong Kong
Despite having numerous new hypoglycemic agents, the principle of
managing diabetes mellitus (DM) relies on old wisdom − Individualization.
The new ADA-EASD position statement points out clearly that avoidance
of hypoglycemia is of prime importance, particularly for those patients who
have significant cardiovascular diseases. Studies show that hypoglycemia
increases the risk of arrhythmias and precipitates heart attack. Incretins play
an important role in glucose metabolism. Both glucagon-like peptide-1 (GLP1) analogues and dipeptidyl peptidase-4 (DPP-4) inhibitors are effective on
blood glucose control in patients with type-2 DM. More importantly, this
class of drugs has less hypoglycemia when comparing to sulphonylureas,
so that they may be better choice for those susceptible patients both as
monotherapy and combination with others like metformin or insulin.

B34

DA WOOD
International Centre for Circulatory Health, Imperial College London, UK
The Joint European Societies Guidelines on CVD prevention updated in
2012 continue to advocate total vascular risk assessment and management.
The European risk estimation model called SCORE (Systematic Coronary
Risk Estimation), based on European populations, is available for high and
low risk countries, and country specific versions are also available. The risk
threshold for more intensive lifestyle intervention and, where appropriate,
the use of drug therapies is now defined as ≥5% fatal CVD risk over 10
years. The inclusion of HDL-cholesterol as a risk factor in SCORE is
highlighted in the most recent version of the prevention guidelines as making
an independent contribution to CVD risk prediction. In addition to calculating
the total SCORE, including HDL-cholesterol, for an individual the physician
has to also take into account other risk factors such as diet, a sedentary
lifestyle, central obesity and evidence of dysglycaemia − impaired fasting
glycaemia or impaired glucose tolerance. All of these factors further increase
the total CVD risk. An electronic version of SCORE called HEARTSCORE
(www.escardio.org/heartscore) is available on the European Society of
Cardiology website and can be downloaded free of charge. Although there
is compelling evidence from randomised controlled trials that reducing LDLcholesterol will reduce total and cardiovascular mortality as well as
cardiovascular morbidity there is little evidence that modifying HDLcholesterol will improve outcomes in high risk patient populations. So HDLcholesterol is an important risk marker but not, at the present time,
a therapeutic target for clinical practice.
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PUBLIC CONFERENCE
2.

How to Choose Functional Foods to Enhance Heart Health

Exercise Workshop

S LAM
Professional Diploma in Diabetes Management and Education (CUHK),
Hong Kong

CKM CHAN,1 JPK LAW2
1
Hong Kong Physiotherapy Association; 2The Hong Kong Society for
Rehabilitation, Hong Kong

Heart disease is the second leading cause of death in Hong Kong. Causes of
heart diseases can be due to poor lifestyle habits such as unhealthy eating
(i.e. high fat, sugar and salt), lack of exercise, smoking, excessive alcohol
consumption and stress. Health professionals including doctors and dietitians/
nutritionists have been trying to deliver messages to encourage the public
to eat a low fat (especially saturated and trans fat), low sugar and salt, and
high fiber diet to lower the risk of heart diseases. But in recently decades,
scientists have also found some "functional foods" that works beyond basic
nutrition. "Functional Foods" is defined as foods and food components that
provide a health benefit beyond basic nutrition. Functional foods may include
conventional foods, fortified, enriched, enhanced foods and also dietary
supplements. Functional foods provide essential nutrients beyond quantities
necessary for normal maintenance, growth, and development. It can also
provide other biologically active components that impart health benefits or
desirable physiological effects. Functional foods for heart health have been
studied extensively in the past years. Examples include oatmeal, soy,
tomatoes, nuts and seeds, fish, flaxseed, tea, red wine, color fruits and
vegetables and more. In this seminar, the scientific evidence based health
benefits and the practical use of these functional foods will be revealed.

Regular exercise program, especially cardiovascular exercise, has many
benefits for heart attack victim or sedentary person. It strengthens our heart
and cardiovascular system, lower blood pressure, reduces low-density
lipoproteins/triglyceride and increase high-density lipoproteins. Exercise
can be divided into three types: stretching, cardiovascular aerobic, muscle
strengthening exercises. Cardiovascular exercise is a steady rhythmical
physical activity using large muscle groups with low impact. Aerobic exercise
includes brisk walking, jogging, bicycling and aerobic dance etc... In order
to achieve maximum benefits, people should gradually work up to an aerobic
session of at least 20 to 30 minutes, at least three to four times a week.
Strengthening exercise is repeated muscle contractions by using dumbbell,
sandbag or theraband. It improves muscle strength, help tone muscles and
increase metabolism. In this exercise workshop, ways to start up an exercise
regimen, obtain target heart rate, self-monitoring techniques and exercise
precautions would be introduced. Moreover, some community resources are
available to reinforce active lifestyle, risk factor modification, regular
exercise habit and to increase patient self esteem and confidence.
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Tobacco Policies and Prevention of Cardiovascular Disease in Asia
JUDITH LONGSTAFF MACKAY,1 ALICE GRAINGER-GASSER,2 MIKI NAKAMURA,3 ROHAN GREENLAND,4
TONY DUNCAN5
From 1Senior Advisor, World Lung Foundation and Director, Asian Consultancy on Tobacco Control; 2Project Manager,
World Heart Federation; 3Executive Secretary, Asia-Pacific Heart Network; 4Director, Government Relations, National
Heart Foundation of Australia; Secretary/Treasurer, Asia-Pacific Heart Network; 5Chief Executive, New Zealand
Heart Foundation and Board Chairman, Asia-Pacific Heart Network
MACKAY ET AL.: Tobacco Policies and Prevention of Cardiovascular Disease in Asia. In nations in which the
tobacco epidemic has declined, in nearly all cases it was physicians who led the way by changing their behaviour
from being one of the groups with the highest smoking prevalence to being one of, if not the, lowest. Therefore, in
any nation where the tobacco epidemic is still large, focusing on reducing smoking among physicians and involving
them in tobacco control activities may be the most important action a national tobacco control movement can take.
Cardiologists have a critical role in the tobacco epidemic. They have close contact with patients, are on the front line
of health care, are well respected and a trusted source of healthcare advice, and should act as role models and
exemplars for healthy behaviour. To reduce cardiovascular disease (CVD) in Asia, CVD health professionals will
need to support on-going tobacco control measures at the population level more strongly, especially the World
Health Organization Framework Convention on Tobacco Control (WHO FCTC), and particularly to advise nonsmokers to avoid second-hand smoke, and support smokers (and other tobacco users) to quit. The traditional medical
model will never be able to reduce tobacco use, and a new paradigm is needed to combat the epidemics of the 21st
century. Proven, effective strategies to reduce the tobacco epidemic are already known, and it only requires political
will, with the support of health professionals, to implement these. (J HK Coll Cardiol 2012;20(Suppl 2):B36-B46)
Health professional, smoking, tobacco, tobacco control
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CVD
WHO FCTC
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The Cardiovascular Disease Epidemic
According to World Health Organization (WHO),
an estimated 17.3 million people died from
cardiovascular diseases (CVDs) in 2008. Over 80% of
CVD deaths take place in low- and middle-income
(LMIC) countries. The epidemic is expanding: by 2030,
almost 23.6 million people will die from CVDs.1
CVD is increasing throughout Asia, resulting in
serious health and economic consequences. South
Asians may be more susceptible to CVD.2 The major
risk factors for CVD in Asia are essentially the same as
in western countries-tobacco, diabetes mellitus,
hypertension and cholesterol.3 Treatment of CVD is
neither available nor affordable to many in the region,
thus the emphasis must be on prevention.

The Tobacco Epidemic
The WHO Global Atlas on Cardiovascular
Disease Prevention and Control entitles the chapter on
tobacco: 'The totally avoidable risk factor of CVDs.'4
Tobacco use is a leading preventable cause of CVD,
causing an estimated 10% of CVD.5 Reduced CVD risk
is one of the most immediate and tangible gains from
reducing tobacco use. The risk of vascular disease falls
to that of a never-smoker inside 5 years of quitting
compared to 30 for lung cancer and 20 for respiratory
disease.6
There are currently about one billion smokers in
the world.4 The tobacco epidemic has persisted in spite
of centuries of knowledge and decades of action,
progress in policy development and public awareness,
multiple World Health Assembly resolutions, 15 World
Conferences since 1967, many regional, national and
sub-national meetings, regional action plans, the World
Health Organization Framework Convention on Tobacco
Control (WHO FCTC) which came into effect in 2005,7
and the 2011 United Nations (UN) High Level Meeting
Summit on NCDs.8
The health effects of tobacco use and exposure
to second-hand smoke are well established, and new
evidence continues to emerge on the mechanism and
extent of the CVD harm.9 There is no safe use of tobacco,
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whether smoked, chewed, sniffed or dissolved.10 Nearly
six million people die from tobacco use and exposure
to second hand smoke each year, accounting for 6% of
all female and 12% of all male deaths in the world. By
2030, tobacco-related deaths are projected to increase
to more than 8 million deaths every year.4 Thus, the
tobacco epidemic is expanding, and is likely to do so
for several decades to come. Even if prevalence rates
are reduced, any benefits will be offset by the increased
numbers of smokers, due to population expansion in
the LMIC.
Most of Asia's smokers are men (Illustrations
1 & 2).11
Health professional students and health
professionals still use tobacco at an unacceptable rate12.13
(Illustration 3). In China, the smoking prevalence among
male physicians is 32%,14 and 13% among male medical
students.15 The prevalence rate among male nurses is
even higher, at 52.2%16 compared with 18.7% among
rural male Japanese nurses (and 10.8% among female
nurses).17

A Call to Action for Health Professionals
Cardiologists have a critical role in the tobacco
epidemic.18,19 They:
• Have close contact with patients
• Are on the front line of health care
• Are well respected and a trusted source of healthcare
advice
• Are role models and exemplars for healthy behaviour
Code of practice: In 2004, WHO produced a
code of practice on tobacco control for health
professional organizations, which has now been
endorsed by major international health organizations,20
including World Heart Federation21 and the Initiative for
Cardiovascular Health Research in Developing
Countries22 (Table 1).
Advocacy: Historically, the medical profession
has played a key advocacy role. One example of
successful advocacy was the UK Royal College of
Physicians publication 'Smoking and Health' in 1962.
It was a seminal piece of work by the medical profession
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Illustration 1. Prevalence of male cigarette smoking by country, 2010 or later.11

Illustration 2. Prevalence of female cigarette smoking by country, 2010 or later.11
B38
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Illustration 3. Smoking prevalence among health professions students.11

Table 1. WHO Code of practice on tobacco control for health professional organizations
Preamble: In order to contribute actively to the reduction of tobacco consumption and include tobacco control in the public
health agenda at national, regional and global levels, it is hereby agreed that health professional organizations will:
1. Encourage and support their members to be role models by not using tobacco and by promoting a tobacco-free culture.
2. Assess and address the tobacco consumption patterns and tobacco-control attitudes of their members through surveys and
introduction of appropriate policies.
3. Make their own organizations' premises and events tobacco-free and encourage their members to do the same.
4. Include tobacco control in the agenda of all relevant health-related congresses and conferences.
5. Advise their members to routinely ask patients and clients about tobacco consumption and exposure to tobacco smoke −
using existing evidence-based approaches and best practices--, give advice on how to quit smoking and ensure appropriate
follow-up of their cessation goals.
6. Influence health institutions and educational centres to include tobacco control in their health professionals' curricula, through
continued education and other training programmes (see Illustration 4).
7. Actively participate in World No Tobacco Day every 31 May.
8. Refrain from accepting any kind of tobacco industry support − financial or otherwise --, and from investing in the tobacco
industry, and encourage their members to do the same.
9. Ensure that their organization has a stated policy on any commercial or other kind of relationship with partners who interact
or with interests in the tobacco industry through a declaration of interest.
10. Prohibit the sale or promotion of tobacco products on their premises, and encourage their members to do the same.
11. Actively support governments in the process leading to the signature, ratification and implementation of the WHO Framework
Convention on Tobacco Control.
12. Dedicate financial and/or other resources to tobacco control − including dedicating resources to the implementation of this
code of practice.
13. Participate in the tobacco-control activities of health professional networks.
14. Support campaigns for tobacco-free public places.
J HK Coll Cardiol, Vol 20 (Suppl 2)
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in changing Government policy. Some cardiologists in
Asia have been outstanding in taking a leadership role
on tobacco control. Other examples are the role of the
medical profession in supporting the WHO FCTC, and
the championing of plain packaging by heart
organizations in Australia. 23 The rationale for
cardiologists' involvement can be summarised:24
• Adult smokers have approximately twice the risk of a
cardiovascular event over 5 to 10 years compared with
non-smokers
• Prospective cohort studies show the beneficial effect
of smoking cessation on coronary heart disease
mortality,25 the benefits being greater than any other
single intervention.
• The excess risk of heart disease is reduced by half
after one year's abstinence and is reduced to the level
of a never smoker within 5 years
• In those with existing heart disease, cessation reduces
the risk of recurrent infarction or mortality by half
• Brief advice to quit is one of the most important
interventions health professionals can deliver and
roughly doubles the chances of long term quitting.26
Cessation. As an example, the Government of
New Zealand has recently introduced a goal to ensure
90% of eligible adults are assessed and appropriately

managed for cardiovascular risk. All patients should be
asked if they smoke and, if the answer is yes, to be
offered brief advice and referral to quitting services.
The Heart Foundation is active in training health
professionals to undertake smoking cessation as part of
their everyday work.
Yet, in much of the world, health professionals
receive no formal training in cessation (see Illustration 4).

Non-smokers
Given the high male smoking rates in Asia, female
non-smokers require special mention. Getting a
woman's husband to stop smoking and her workplace
to go smoke-free is nearly as important for her health
as reducing her salt and giving her BP medication.27

CVD Organizations
There are several global, regional and national
CVD foundations, such as the World Heart Federation
(WHF),28Asian Pacific Cardiology Society (APCS)29
and the Asia-Pacific Heart Network (APHN).30 World
Stroke Organization (WSO),31 and Asia Pacific Stroke
Organization (APSO).32 Historically, these organizations
have focussed more on hypertension, cholesterol, and
intervention and treatment, rather than on tobacco.
Tobacco has rarely been a Keynote or Plenary topic at

Illustration 4. The lack of formal training in patient counselling13
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CVD conferences, and few cardiologists attend the
triennial World Conferences on Tobacco or Health. This
is now changing, with tobacco sessions at CVD
meetings, albeit usually less well attended than those
revealing the latest in intervention gadgetry.
"Advancing a tobacco free world" is a pillar of
World Heart Federation (WHF) 2010-2015 strategy. In
2010 the WHF launched an initiative to engage
cardiologists in tobacco cessation and control at its
World Congress of Cardiology (WCC) in Beijing and
created a film and pamphlet on CVD and secondhand
smoke to disseminate findings from the IOM report. In
2011-2012 WHF developed the initiative further through
the project Engaging Cardiologists in Tobacco Control.
This involved:
• Co-publishing the report Cardiovascular Harms of
Tobacco Use and Exposure to Secondhand Smoke:
Global Gaps in Awareness and Implications for
Action.33
• Mapping cardiologists and member organizations
engaged in tobacco control around the world.
• Organizing a regional workshop at the World
Conference on Tobacco or Health, in 2012 in
Singapore with APHN and Global Smokefree
Partnership (GSP) for APHN/WHF member
organizations.
• Organizing a workshop at the WCC 2012 in Dubai
for cardiologists and member organizations from
around the world, particularly from the Middle East.
• Publishing an issue focused on tobacco control in
Global Heart, the WHF journal.
Through these activities, the WHF has developed
a network of cardiologists/heart health organizations
from around the world who are engaged in tobacco
cessation and control. It has also identified barriers and
opportunities for increasing cardiologists' engagement
in tobacco cessation and control. As an outcome to its
activities, Asia-Pacific Heart Network developed a
regional strategy for mobilizing its member
organizations to take action in tobacco control (The
APHN's 'Heart Charter' − modelled on the European
Heart Health Charter), and the Asian Pacific Society
of Cardiology (APSC) has endorsed the strategy.
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Subsequently, the Philippines Heart Association and
Chinese Cardiology have held meetings on tobacco and
heart health and the APHN plans to have a member
meeting on tobacco at the 2013 APSC conference.
The APHN has stated: "The Regional Plan sets
out the need for all Asia-Pacific nations to have medical
societies, associations and heart foundations talking
leadership and responsibility to support our over-arching
goal of reduction of tobacco use for more effective
prevention of CVD. It is clearly professionally
inappropriate to continue to build clinical services for
disease management without balancing this with
enhanced preventive measures to stem the tide of CVD
in the region."
Individual country heart foundations have taken
strong action, for example: Bangladesh Heart
Foundation leads a national coalition that aims to engage
physicians in tobacco control. The Indonesian Heart
Foundation hosts a national coalition that has supported
advertising bans and smoke-free policy.

FCTC
The WHO FCTC, which came into effect in 2005,
has now been adopted by 176 parties,34 covering 87.4%
of world population. It represents a paradigm shift in
developing a regulatory strategy to improve health,35
one that might in future be considered for other CVD
risk factors. The Western Pacific Region is still the only
WHO region in which every single country has ratified
the Convention (see Table 2), but Indonesia in the South
East Asia region has yet to become a signatory or to
ratify.

MPOWER
In 2008, recognising the need to advance cost
effective measures and to help countries fulfil some of
their WHO FCTC obligations, WHO introduced in 2008
the 'MPOWER' package of six evidence-based tobacco
control demand reduction measures, offering a useful
framework for action (Table 3). Under the MPOWER
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structure WHO publishes biannual series of Reports on
the Global Tobacco Epidemic, which provide an
unprecedented level of detail and roadmaps for effective
solutions.36

Role of Government
There is robust evidence that tobacco control is
cost-effective compared with other health interventions.35
"Best buy" proven, effective interventions include
tobacco tax increases, restrictions on smoking in public
places and workplaces, comprehensive bans on all
promotion, and timely dissemination of information
about the health risks of smoking.35 It only requires

political will to implement these, and here the influence
of the CVD professional is key.
At national level, there are some measures that
only governments can mandate, such as smoke-free
areas, health warnings and bans on all promotion,
remove business operating licences for non-compliance
of smoke-free legislation or of bans on sales to youth,
implement taxation policy, and ratify UN treaties, such
as the WHO-FCTC. This works best when supported
by civil society. This also means political lobbying
must be high on the agenda of anyone hoping to
influence public health policy and reduce CVD.
Article 5.3 of the FCTC warns against tobacco
industry interference with government public health
policies, which applies to all sectors of government. The

Table 2. Main provision of FCTC11

Table 3. MPOWER37
WHO MPOWER
M
Monitor tobacco use and prevention policies
P
Protect people from tobacco smoke
O
Offer help to quit tobacco use
W
Warn about the dangers of tobacco
E
Enforce bans on tobacco advertising, promotion and sponsorship
R
Raise taxes on tobacco

WHO FCTC Article
20,21
8
14
11,12
13
6
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accompanying Guidelines state: Parties should not allow
any official or employee of government or of any
semi/quasi-governmental body to accept payments, gifts
or services, monetary or in-kind, from the tobacco
industry.38 Dr Margaret Chan, the Director General of
WHO, said "It is horrific to think that an industry known
for its dirty tricks and dirty laundry could be allowed to
trump what is clearly in the public's best interests".39

Role of Civil Society
Other major achievements include strengthening
of the international non-governmental movement
against tobacco, for example, continuing and expanded
world conferences on tobacco or health; the
establishment of the International Network of Women
Against Tobacco (established 1990);40 the Framework
Convention Alliance (1999);41 the NCD Alliance,42 and
international web-based networks on tobacco. There has
been a significant increase in research on the health
effects and economic costs of tobacco, and on the
behaviour of the tobacco companies.

Role of Employers
Tobacco is an occupational health and safety
issue. Employers have a responsibility to provide a safe,
healthy, smoke-free environment for employees in line
with their duties of worker protection, reinforced by
research studies on hospitality workers.43-45 and policy
guidelines from UN agencies,46,47 and noting that such
legislation does not cause economic harm or job
losses.

foundations, such as the Bloomberg Initiative to Reduce
Tobacco Use in Low and Middle Income Countries,49
the Bill and Melinda Gates Foundation50 and others. Yet
government funding remains inadequate, especially for
the implementation of the WHO FCTC.

Obstacles to Tobacco Control
The obstacles to tobacco control are surprisingly
similar around the world, and are summarised in
Table 4.

Conclusion
It usually takes at least a century from
identification to eradication of epidemics such as
smallpox and polio, so perhaps it is not surprising that
it is taking decades to eradicate tobacco use.
The harmfulness of tobacco in causing CVD is
established beyond doubt. The epidemic is completely
preventable through political will, and proven tools
exist to reduce this epidemic. There have been great
successes, such as reduction in smoking prevalence rates
in many parts of the world, and the introduction and
strengthening of tobacco control legislation and tobacco
taxation.
A new paradigm is needed for CVD organizations
and professional to address the CVD epidemic and their
risk factors, such as supporting international treaties,
laws and taxation.
In addition to the clinical role, the single most
useful action any cardiologist in Asia can take to
improve CVD health is to become engaged in full
FCTC implementation.
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Table 4. Obstacles to implementing tobacco control policies
1. Tobacco industry: promotion, distortion of health and economic evidence,* financial might, challenge/threats to governments
and to tobacco control policy, tobacco-industry funded research, buying undue influence and the use of neo-libertarian front
groups.
2. Lack of awareness of the risk or of the magnitude of risk of tobacco as a risk factor for CVD.
3. Preoccupation with diseases that may have much less serious consequences, or with war, natural disasters or the financial
crises.
4. Comparative lack of active involvement by health (including CVD) professionals or CVD organisations in tobacco control.
5. Tobacco may not yet cause many deaths in some places where life expectancy is low.
6. Focus on curative medicine, not prevention.
7. Smoking may be seen as personal behaviour and human right.
8. Tobacco tax revenue (but not debit) seen by governments.
9. Misperceived concern about economic losses to the country, farmers and manufacturers if tobacco control measures taken.
10. Insufficient resources for research, surveillance and evaluation, implementation of laws, or to combat smuggling.
11. Difficulty for some governments to work with civil society, NGOs and academia.
12. Media may be uninformed or even offer 'equal time' to the industry.
13. No understanding of environmental consequences-fires, cutting down wood to cure tobacco, billions of cigarette ends,
matches, lighters discarded daily.
14. The Millennium Development Goals make no mention of NCDs.
15. No targets.
16. Many laws have loopholes and are neither sufficiently specific nor comprehensive.#
17. Some educational messages are difficult to understand. There needs to be very clear, simple messages such as "Tobacco kills
one in two smokers."51
*The 1990's United States court ruling to place tobacco industry documents in the public domain52 showed that the tobacco industry has
known all along their product is harmful, lethal and addictive, while publicly denying the evidence.
#An example is the most recent legislative mistake in Hong Kong, putting the legal onus on the smoker in the ban on smoking in restaurants and bars, an error still in place. Thus owners and managers have little incentive in maintaining smoke-free premises.
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Lipid Treatment Update
MIAO HU and BRIAN TOMLINSON
From Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital,
Hong Kong
HU and TOMLINSON: Lipid Treatment Update. Statin therapy has become the mainstay of treatment for reduction
of low-density lipoprotein cholesterol (LDL-C) to reduce cardiovascular risk and more intensive statin therapy provides
additional risk reduction. Mono-therapy with statins may be insufficient in subjects with very high baseline LDL-C
and some patients are intolerant of statin treatment or may have adverse drug interactions and more intensive statin
treatment is associated with a small increase in the risk of developing diabetes. Combining statins with ezetimibe
may result in more effective reduction of LDL-C but whether this combination results in improved outcomes compared
to more intensive statin therapy remains to be proven. New forms of therapy to reduce LDL-C with monoclonal
antibodies to proprotein convertase subtilisin/kexin 9 (PCSK9) or antisense oligonucleotides to apolipoprotein B100 are currently under development and can result in more effective reduction of LDL-C. For patients with combined
dyslipidaemia with elevation of triglycerides and lower levels of high-density lipoprotein cholesterol there are the
options of adding niacin or fibrates. Beneficial effects have been seen in some outcomes with these treatments and
ongoing studies may help to define the role of niacin in some patient groups. Some of these questions will be
answered by the ongoing studies but optimization of lipid-modifying treatment for individual patients is likely to
remain an uncertainty for many years to come. Statin therapy is likely to remain the cornerstone of treatment, but
combinations with other drugs will become more popular. (J HK Coll Cardiol 2012;20(Suppl 2):B47-B52)
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Current Pharmacological Therapy
Statins
There is extensive evidence from large clinical
trials that reduction of low-density lipoprotein
cholesterol (LDL-C) with the 3-hydroxy-methylglutaryl
coenzyme A (HMG-CoA) reductase inhibitors or statins
is effective in reducing cardiovascular events. The
benefits of statin treatment in various patient groups,
including primary and secondary prevention and patients
with diabetes, have been demonstrated in several studies
and in a number of meta-analyses,1-3 and these findings
have recently been extended to people at low risk of
vascular events.4 In a meta-analysis from the Cholesterol
Treatment Trialists' (CTT) Collaboration comparing
more intensive lipid lowering regimens with statins with
less intensive regimens, the more intensive treatments
produced significant additional reductions of 15% (95%
CI 11-18; p<0.0001) in major vascular events, including
reductions in coronary death or non-fatal myocardial
infarction of 13% (95% CI 7-19; p<0.0001) and
reductions in ischaemic stroke of 16% (95% CI 5-26;
p=0.005). 5 However, it should be noted that in the
SEARCH (Study of the Effectiveness of Additional
Reductions in Cholesterol and Homocysteine) trial,
despite an additional average reduction of LDL-C of
0.35 (SE 0.01) mmol/L with simvastatin 80 mg daily
compared to 20 mg daily, there was no significant
reduction in major vascular events and there was an
increase in cases of myopathy in the 80 mg daily
group.6 A genome-wide association study in 85 subjects
with definite or incipient myopathy and 90 controls
taking 80 mg of simvastatin daily from that trial found
a single strong association of myopathy with a singlenucleotide polymorphism (SNP) in the SLCO1B1 gene
encoding the organic anion-transporting polypeptide
OATP1B1, which regulates the hepatic uptake of
statins.7
Statins have a range of pleiotropic effects in
addition to lowering LDL-C and the JUPITER
(Justification for the Use of statins in Primary
prevention: an Intervention Trial Evaluating
Rosuvastatin) study showed that the inflammatory
marker high-sensitivity C-reactive protein (hsCRP) was
an additional target for statin treatment,8 and assessment
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of hsCRP has been adopted in some of the newer
guidelines for lipid treatment. However, it remains
controversial as to whether hsCRP should be regarded
as a risk factor or risk marker.9
Although statins have become the mainstay
of treatment for reduction of LDL-C to reduce
cardiovascular risk and are generally very safe, adverse
effects e.g. muscle toxicity from mild muscle symptoms
to the most severe condition of rhabdomyolysis occur,
especially with higher doses.10 Moreover, the JUPITER
study showed an increased risk of new onset diabetes
with rosuvastatin 20 mg daily compared to placebo,11
and a recent meta-analysis showed that more intensive
statin treatment is associated with an increased risk of
developing diabetes compared to less intensive
treatment (Odds ratio: 1.12, 95% CI 1.04-1.22). 12
However, given the overwhelming benefit of statins in
the reduction of cardiovascular events by 25% to 45%,
the small absolute risk for development of diabetes is
outweighed by the cardiovascular benefits in patients
for whom statin therapy is recommended and the clinical
practice for statin therapy should not be changed.13
In some patients with very high cardiovascular
risk who have the lowest LDL-C targets or with very
high baseline LDL-C such as those with familial
hypercholesterolaemia, monotherapy with statins may
be insufficient to achieve recommended goals.
Combination therapy with other lipid-regulating agents
might be required to further improve the lipid levels.14

Ezetimibe
Ezetimibe is a selective cholesterol absorption
inhibitor, which reduces cholesterol levels by blocking
the intestinal uptake of dietary and biliary cholesterol,
without affecting absorption of fat-soluble vitamins or
triglycerides.15 When administered as monotherapy,
ezetimibe 10 mg can reduce LDL-C by approximately
17% in patients with primary hypercholesterolaemia.16
However, co-administration of ezetimibe with a statin
provides addition reductions in LDL-C by about 15 to
20% compared with statin monotherapy because of their
complementary mechanisms of actions as there is a
significant and consistent increase of cholesterol
absorption with statin therapy that is correlated with
the inhibition of cholesterol synthesis.16,17
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The early outcome studies with ezetimibe were
disappointing as there appeared to be no benefit from
the addition of this drug to simvastatin in the
ENHANCE (Ezetimibe and Simvastatin in
Hypercholesterolemia Enhances Atherosclerosis
Regression) trial in the change in carotid-artery
intima-media thickness in patients with familial
hypercholesterolaemia,18 and in the SEAS (Simvastatin
and Ezetimibe in Aortic Stenosis) trial ezetimibe added
to simvastatin did not reduce events related to aorticvalve stenosis.19 In retrospect, both these trials had
methodological problems and more recently the SHARP
(Study of Heart and Renal Protection) trial was the first
study to show significant reduction in major
atherosclerotic events with lipid lowering treatment in
a wide range of patients with advanced chronic kidney
disease, in this case with simvastatin 20 mg plus
ezetimibe 10 mg daily.20 The IMPROVE-IT (Improved
Reduction of Outcomes: Vytorin Efficacy International
Trial) should help to clarify the role of ezetimibe in
clinical practice.21

Niacin
Niacin has been used for the treatment of
dyslipidaemia for over 50 years.22 It has favorable effects
on all traditionally measured lipid parameters, e.g.
reducing LDL-C, triglyceride and lipoprotein(a) levels
and raising high-density lipoprotein cholesterol (HDLC).23 Lipoprotein(a) has been recognized as an important
risk factor which does not respond to other therapies.24
The common side effects of niacin include
vasocutaneous flushing, increased plasma glucose and
uric acid levels and gastrointestinal adverse effects.23
Several clinical studies have indicated that treatment
with niacin, alone or in combinations mainly with
statins, significantly reduces total mortality and
coronary events and retards the progression of and may
induce the regression of coronary atherosclerosis.22, 23,25
Treatments to increase HDL-C have been of great
interest because of the strong inverse relationship
between HDL-C levels and cardiovascular events in
epidemiological studies.26 This relationship appears to
hold true even when LDL-C has been reduced with
intensive statin therapy.27 The ARBITER-6-HALTS
(Arterial Biology for the Investigation of the Treatment
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Effects of Reducing Cholesterol-6-HDL and LDL
Treatment Strategies) study demonstrated that in patients
who had coronary heart disease (CHD) or a CHD risk
equivalent, who were receiving long-term statin therapy,
and in whom the LDL-C level was <2.6 mmol/L and
HDL-C was <1.3 or <1.4 mmol/L for males and females
respectively, niacin as add-on therapy to statin treatment
resulted in a significant improvement in the surrogate
endpoint of carotid intima-media thickness.28 However,
the recent AIM-HIGH (Atherothrombosis Intervention
in Metabolic Syndrome with Low HDL/High
Triglyceride and Impact on Global Health Outcomes)
study showed that raising HDL-C levels by niacin did
not result in additional reduction in cardiovascular
events in patients receiving intensive statin therapy who
had low baseline HDL-C levels and optimal LDL-C
levels.29 This result has generated debate on the utility
of raising HDL-C levels in general and in particular
with niacin therapy. Furthermore, recent mendelian
randomisation analyses showed that SNPs that
exclusively associate with HDL-C, such as the loss-offunction coding SNP at the endothelial lipase gene
(LIPG Asn396Ser), do not seem to lower the risk of
myocardial infarction whereas SNPs influencing LDLC had effects concordant with those expected from
observational studies, suggesting that a low HDL-C level
per se may not be a true cardiovascular risk factor.30
However, the AIM-HIGH study had some limitations
and was underpowered to test the potential benefits of
adding niacin to statin-treated patients considering the
small difference in HDL-C between the treatment
groups. Hopefully, the ongoing HPS2-THRIVE (Heart
Protection Study 2: Treatment of HDL to Reduce the
Incidence of Vascular Events) study that tests the effects
of niacin with laropiprant, which inhibits the niacininduced flushing reaction, and has randomised 25,000
participants including a large number of Chinese
patients will demonstrate whether niacin is really
effective in reducing events in addition to adequate statin
therapy.23

Fibrates
Fibrates, such as fenofibrate, result in a
substantial decrease in plasma triglycerides and this is
usually associated with a modest decrease in LDL-C
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and an increase in HDL-C concentrations.31 However,
in patients with high triglyceride levels, LDL-C levels
may increase, probably due to an increase in LDL
particle size.14 Clinical studies of the effect of fibrates
on cardiovascular disease have yielded mixed results,
but the recent meta-analysis including more than
45,000 individuals with a broad range of baseline
characteristics has shown that fibrate therapy produced
a 10% relative risk reduction (95% CI 0-18%) for major
cardiovascular events (p=0.048) and a 13% relative risk
reduction (95% CI 7-19%) for coronary events
(p<0.0001), but had no benefit on stroke (-3% relative
risk reduction, 95% CI -16 to 9).32 This analysis suggests
that fibrates can reduces the risk of cardiovascular
disease by preventing coronary events and clinically
meaningful reductions in risk could be achieved in
individuals at high risk of cardiovascular events and in
those with combined dyslipidaemia. In the ACCORD
(Action to Control Cardiovascular Risk in Diabetes)
study, addition of fenofibrate to simvastatin in patients
with diabetes did not result in significant reduction of
cardiovascular events in the study overall, but there was
a significant benefit in a pre-selected subgroup of
patients with both high triglyceride and low HDL-C
levels, which may be the obvious group to treat with
this drug.33

Investigational Agents
Antisense Oligonucleotides to apo B
Apolipoprotein B (apo B) is an important
structural and functional component of all atherogenic
lipid particles and is required for the secretion of very
low-density lipoprotein (VLDL) from the liver so
reduction in apo B synthesis is expected to reduce
circulating VLDL and LDL-C levels. Mipomersen (ISIS
301012) is an antisense oligonucleotide that targets
apo B-100 and inhibits apo B production.34 In a doubleblind, randomized, placebo-controlled, dose-escalation
study utilizing an initial dose of 50-400 mg followed
by 4 weeks of additional multiple dosing of mipomersen
(given intravenously and subcutaneously) with the same
assigned dose in 36 volunteers with mild dyslipidaemia,
mipomersen was associated with dose-dependent
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reductions in levels of apo B by up to 50% from baseline
accompanied by a maximum 35% reduction of
LDL-C.35 Subsequent studies in patients treated with
statins with LDL-C 100-220 mg/dl showed mipomersen
200 mg per week for 13 weeks reduced apo B and
LDL-C levels by about 35%. 36 A further phase III
study in patients with homozygous familial
hypercholesterolaemia already taking maximum
tolerated doses of conventional lipid-lowering drugs has
revealed that mipomersen at 200 mg per week for
26 weeks provided a further mean 25% decrease in
LDL-C levels. 37 The most common side effects of
mipomersen are injection site reactions (70%-100%),
flu-like symptoms (29%-46%), and elevated
transaminases associated with an increased liver fat
content (6%-15%).34

PCSK9 Antibodies
The discovery that mutations and polymorphisms
in the gene for proprotein convertase subtilisin/kexin 9
(PCSK9) modulate expression of the LDL receptor and
are associated with changes in LDL-C, familial
hypercholesterolaemia and coronary artery disease was
an important development in the understanding of lipid
metabolism processes. 38,39 This has led to the
development of biological agents that can influence this
protein and initial studies with a monoclonal antibody
to PCSK9 from Regeneron Pharmaceuticals called
REGN727 given intravenously or subcutaneously
showed effective reductions in LDL-C with a good
safety profile.40 Another compound AMG 145 from
Amgen, which is a fully human monoclonal
immunoglobulin G2 antibody that binds specifically to
human PCSK9, is being tested in the LAPLACE-TIMI
57 (LDL-C Assessment with PCSK9 Monoclonal
Antibody Inhibition Combined With Statin TherapyThrombolysis In Myocardial Infarction) trial.41 Several
other monoclonal antibodies targeting PCSK9 in the
circulation are also under development e.g. RN316 IgG
(Pfizer-Rinat) and 1D05-IgG (Merck). 14 In phase I
studies in healthy subjects and phase II studies in
patients with hypercholesterolaemia treated with statins,
these PCSK9 antibodies given intravenously or
subcutaneously significantly reduced LDL-C levels by
up to 70% relative to placebo with no evidence of drug-
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related adverse events observed. 42 These initial
promising data indicate that pharmacologically induced
PCSK9 inhibition is efficacious in the reduction of
LCL-C levels and future outcome studies are needed to
determine the beneficial effects of PCSK9 inhibition
on CVD risk reduction.

clarification from ongoing clinical trials. The
investigational agents including CETP inhibitors,
antibodies to PCSK9, antisense oligonucleotides to
apo B-100 and other agents in development offer the
exciting prospect of further modification of lipid risk
factors and reduction of cardiovascular events in the
years to come.

Cholesteryl Ester Transfer Protein Inhibitors
The inhibitors of cholesteryl ester transfer protein
(CETP) have provided a novel approach to increase
HDL-C, and with some of the drugs in this group
additional substantial reductions in LDL-C can also be
achieved. However, the findings in the ILLUMINATE
(Investigation of Lipid Level Management to Understand
its Impact in Atherosclerotic Events) study with
torcetrapib of an increased risk of cardiovascular events
(hazard ratio [HR], 1.25; 95% CI 1.09-1.44; p=0.001)
and increased all-cause mortality (HR, 1.58; 95% CI
1.14-2.19; p=0.006) despite a 72% increase in HDL-C
and 25% decrease in LDL-C resulted in the withdrawal
from development of that drug.43 The increased risk
appeared to be due to off-target effects causing increases
in systolic blood pressure and serum aldosterone and
the other CETP inhibitors do not seem to have these
effects. Development continues with the two remaining
CETP inhibitors, anacetrapib and evacetrapib, which
appear to be more effective in increasing HDL-C and
decreasing LDL-C than was the case with dalcetrapib,
which was also withdrawn from development earlier this
year because of apparent lack of efficacy in the phase
III study.44,45

Conclusion
Statins have proven to be the most effective lipid
modifying treatment and are likely to continue to occupy
this position for the foreseeable future. Intensive statin
therapy provides additional cardiovascular benefits but
with increased risk of myopathy and a slight increase
in the risk of new onset diabetes. Additional lowering
of LDL-C can be achieved by combining statins with
ezetimibe and combinations of statins with niacin or
fibrates can further improve triglyceride and HDL-C
levels. The exact role of these combinations still requires
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Preface
It gives us great pleasure to welcome you to this biennial conference, the 4th Asian Preventive Cardiology and
Cardiac Rehabilitation Conference (APCCRC). Concerted effort of our College and continuous support from
20 supporting organizations including government, non-government, academic, service organizations as well
as patient groups to conduct this conference demonstrates our dedication to prevention of heart diseases.
Over the past decade, the APCCRC has grown to be one of the major international conferences on Preventive
Cardiology and Cardiac Rehabilitation. We shall continue to address on the prevention strategies against
cardiovascular diseases with special emphasis on the control of various disk factors namely hypertension,
hyperlipidemia, smoking, diabetes mellitus and obesity. There will also be updates on the various pharmacological
advancements in the field of preventive cardiology.
The conference will begin with the Heart Foundation Lecture delivered by an unforgettable keynote speaker,
Prof. David A. Wood from Imperial College London. He will talk on future prevention in cardiac diseases and
Prof. Wood will enlighten us further on the controversy of HDL-cholesterol on the second day of the conference.
This year, the Best Abstract & Best Poster Award has attracted a record-high submission of high quality abstracts
& cases from local and overseas research colleagues from 17 regions and countries.
Meanwhile, due to many positive feedback received in 2010, there will be again the Jump Rope for Heart Public
Conference conducted in Chinese for the local public for the enhancement of the knowledge and skills in selfmanagement of patients and their carers.
We are looking forward to your contribution and participation. Your continuous support is a huge vote of
confidence for us to keep hosting this conference.
See you in Hong Kong again for APCCRC 2014!

Dr. Ngai-yin CHAN
Co-Chairman
Executive Committee
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Dr. Leonard Sheung-wai LI
Co-Chairman
Executive Committee
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11. RATES OF ATTENDANCE AT A SMOKING CESSATION CLINIC WITHIN
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